<SEC-DOCUMENT>0001683168-22-001373.txt : 20220302
<SEC-HEADER>0001683168-22-001373.hdr.sgml : 20220302
<ACCEPTANCE-DATETIME>20220301205621
ACCESSION NUMBER:		0001683168-22-001373
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20220301
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220302
DATE AS OF CHANGE:		20220301

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		22700894

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>radnet_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:RDNT="http://radnet.com/20220301">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_031_RDNT_radnet.com_20220301 -->
<!-- Field: Set; Name: xdx; ID: xdx_047_20220301_20220301 -->
<!-- Field: Set; Name: xdx; ID: xdx_05C_edei%2D%2DEntityCentralIndexKey_0000790526 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:EntityCentralIndexKey">0000790526</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-03-01to2022-03-01" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rdnt-20220301.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-03-01to2022-03-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-03-01</xbrli:startDate>
        <xbrli:endDate>2022-03-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">UNITED STATES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Washington, D.C. 20549</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 14pt"><b>FORM
<span id="xdx_90C_edei--DocumentType_c20220301__20220301_zkP7l4WtVGk5"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 25%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Date of Report (Date of
earliest event reported <span id="xdx_90D_edei--DocumentPeriodEndDate_c20220301__20220301_z2abgiF1vmm4"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">March 1,
2022</ix:nonNumeric></span>)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">_______________________________________________</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90A_edei--EntityRegistrantName_c20220301__20220301_zr2asZ3jraA4"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:EntityRegistrantName">RadNet, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Exact name of registrant
as specified in its charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<hr style="border-width: 0; color: Gray; background-color: Gray; height: 1px; width: 100%; margin-top: 3pt; margin-bottom: 3pt" />
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 10pt; width: 33%"><b><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_c20220301__20220301_zgQo0cnjkMqd"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></td>
    <td style="text-align: center; padding-left: 10pt; width: 33%"><span id="xdx_902_edei--EntityFileNumber_c20220301__20220301_zhH9BkTUmybi"><b><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:EntityFileNumber">001-33307</ix:nonNumeric></b></span></td>
    <td style="text-align: center; width: 33%"><span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20220301__20220301_zqXAvALLFurf"><b><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:EntityTaxIdentificationNumber">13-3326724</ix:nonNumeric></b></span></td></tr>
<tr style="vertical-align: top">
    <td style="text-align: center; padding-left: 10pt">(State or other jurisdiction<br />

of incorporation)</td>
    <td style="text-align: center; padding-left: 10pt">(Commission File Number)</td>
    <td style="text-align: center">(IRS
Employer Identification Number)</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 60.9pt; text-indent: -16.75pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font-size: 10pt; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 49%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_906_edei--EntityAddressAddressLine1_c20220301__20220301_zxDAvbkleBig"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:EntityAddressAddressLine1">1510 Cotner Avenue</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityAddressCityOrTown_c20220301__20220301_zbkFTGPKAiMi"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:EntityAddressCityOrTown">Los Angeles</ix:nonNumeric></span>, <span id="xdx_907_edei--EntityAddressStateOrProvince_c20220301__20220301_zvdxPgR6tGFb"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span></b></p></td>
    <td style="width: 51%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20220301__20220301_zdS2OwepN4f6"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:EntityAddressPostalZipCode">90025</ix:nonNumeric></span></b></p></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Address of principal executive offices)</span></td>
    <td style="font-size: 10pt; text-align: center"><span style="font-size: 10pt">(Zip Code)</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(<span id="xdx_90E_edei--CityAreaCode_c20220301__20220301_zSKG0oJMjfcb"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:CityAreaCode">310</ix:nonNumeric></span>) <span id="xdx_90D_edei--LocalPhoneNumber_c20220301__20220301_z9Ai1bTb3UVj"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:LocalPhoneNumber">478-7808</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">(Registrant&#8217;s Telephone Number, Including Area Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span style="font-family: Wingdings"><span id="xdx_906_edei--WrittenCommunications_c20220301__20220301_zlxMGjrw87sh"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span style="font-family: Wingdings"><span id="xdx_909_edei--SolicitingMaterial_c20220301__20220301_zLPQVsqBNZR1"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span style="font-family: Wingdings"><span id="xdx_90E_edei--PreCommencementTenderOffer_c20220301__20220301_z5R5v7wbYss3"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5.7pt"></td><td style="width: 21.5pt"><span style="font-family: Wingdings"><span id="xdx_907_edei--PreCommencementIssuerTenderOffer_c20220301__20220301_z4RF8ssHHGP1"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">Securities registered pursuant to Section
12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Title of Each Class</span></span></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center; width: 34%"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Trading Symbol(s)</span></span></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Name of each exchange on which registered</span></span></td></tr>
<tr>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--Security12bTitle_c20220301__20220301_z3uT4O3aWWVb"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:Security12bTitle">Common Stock, $.0001 par value</ix:nonNumeric></span></span></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90C_edei--TradingSymbol_c20220301__20220301_zXiIQML9bnq9"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" name="dei:TradingSymbol">RDNT</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom; font-size: 10pt; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--SecurityExchangeName_c20220301__20220301_zeSsGrfmzu5b"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ Global Market</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company&#160;&#160;&#160;</span><span style="font-family: Wingdings"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20220301__20220301_zr7eFf8GL3kg"><ix:nonNumeric contextRef="From2022-03-01to2022-03-01" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;
</span><span style="font-family: Wingdings">&#168;</span></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in">Item 2.02</td><td>RESULTS OF OPERATIONS AND FINANCIAL CONDITION</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 1, 2022 RadNet, Inc.
(&#8220;RadNet&#8221;) issued a press release and held a conference call regarding our 2021 financial results for the fourth quarter and
full fiscal year ended December 31, 2021. A copy of the press release is furnished as Exhibit 99.1 and a copy of the transcript of the
conference call is furnished as Exhibit 99.2 to this Current Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The information in this Current
Report, including Exhibit 99.1 and Exhibit 99.2 is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section
18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section. The information in this Current Report,
including Exhibit 99.1 and Exhibit 99.2 shall not be incorporated by reference into any registration statement or other document filed
with the Commission.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 9.01</b></td><td style="text-align: justify"><b>FINANCIAL STATEMENTS AND EXHIBITS.</b></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 15%"><span style="text-decoration: underline">Exhibit Number</span></td>
  <td style="width: 85%"><span style="text-decoration: underline">Description of Exhibit</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>99.1</td>
  <td><a href="radnet_ex9901.htm">Press Release dated March 1, 2022 relating to RadNet, Inc.&#8217;s financial results for the quarter and full fiscal year ended December 31, 2021</a></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>99.2</td>
  <td><a href="radnet_ex9902.htm"><span style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transcript of Conference Call </span></span></a></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>

<tr style="vertical-align: top; text-align: left">
  <td>104</td>
  <td>Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal"></span></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SIGNATURE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 50%; font-size: 10pt">Date:&#160;&#160;March 1, 2022</td>
    <td style="text-align: left; width: 50%; font-size: 10pt"><b>RADNET, INC.</b></td></tr>
  <tr style="vertical-align: top">
    <td style="font-size: 10pt">&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">By: <span style="text-decoration: underline">/s/ Mark D. Stolper</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">Name: Mark D. Stolper<br />
    Title: Chief Financial Officer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT INDEX</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
  <td style="width: 15%"><span style="text-decoration: underline">Exhibit Number</span></td>
  <td style="width: 85%"><span style="text-decoration: underline">Description of Exhibit</span></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>99.1</td>
  <td><a href="radnet_ex9901.htm">Press Release dated March 1, 2022 relating to RadNet, Inc.&#8217;s financial results for the quarter and full fiscal year ended December 31, 2021</a></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>99.2</td>
  <td><a href="radnet_ex9902.htm"><span style="font-weight: normal"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transcript of Conference Call </span></span></a></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td></tr>

<tr style="vertical-align: top; text-align: left">
  <td>104</td>
  <td>Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-weight: normal">&#160;</span></p>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>


</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KwjAMhZ9g7xB6LdpNBbdLh4o4ZYwh3hYXpbg1I61/j+Rb2m2IIRCSc74cIUZiQ2tdI8NpWWRQYtPWyiEUeEFGc0bvSLe7BPws8KqtY2Vcv/7AlDyDnpmPY+XvvfOhLVYJyMVExpMoBDlL5BTyvQg6PSVz0RUap1UNylSQM7Ws0Sl+Dx9K9SJDzbtPOiJbTSaBcCwH+QORDCM40EM9iW8WsiwVwaivQGyY7m0Xc7eOGljV2PgsO6D/Dr7iWkkg -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>radnet_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;<IMG SRC="logo.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">FOR IMMEDIATE RELEASE</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RadNet Reports Fourth Quarter 2021 Results and Releases 2022 Financial
Guidance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Revenue increased 8.0% to $333.2 million in the fourth quarter of 2021
from $308.5 million in the fourth quarter of 2020</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Adjusted EBITDA<SUP>(1)</SUP> increased 7.5% to $54.5 million in the fourth
quarter of 2021 from $50.7 million in the fourth quarter of 2020</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>RadNet estimates that its Adjusted EBITDA<SUP>(1)</SUP> was negatively
impacted by the most recent Omicron surge of COVID-19 by approximately $3 million during the fourth quarter of 2021</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Adjusting for unusual or one-time items impacting Net Income in the quarter,
Adjusted Earnings Per Share<SUP>(3)</SUP> was $0.13 for the fourth quarter of 2021; This compares with Adjusted Earnings Per Share<SUP>(3)</SUP>
of $0.20 for the fourth quarter of 2020 </I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Aggregate procedural volumes increased 11.4%; Same-center procedural volumes
increased 7.3% compared to the fourth quarter of 2020</I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>At quarter end, Net Leverage Ratio (Net Debt divided by Trailing 12 Month
Adjusted EBITDA<SUP>(1)</SUP>) was 2.9x; RadNet ended 2021 with a cash balance of $134.6 million and undrawn on its $195 million revolving
line of credit </I></FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>RadNet announces 2022 guidance ranges, anticipating increases in Revenue
and Adjusted EBITDA<SUP>(1)</SUP> for 2022 over 2021 (as adjusted for one-time benefits recognized in 2021 from provider relief funding
and employee retention credit under the CARES Act)</I></FONT></TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LOS ANGELES, California, March 1, 2022 &ndash;
RadNet, Inc. (NASDAQ: RDNT),</B> a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging
services through a network of 347 owned and/or operated outpatient imaging centers, today reported financial results for its fourth quarter
and full year ended December 31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Financial Results</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Fourth Quarter Report:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief Executive
Officer of RadNet, commented &ldquo;Despite being impacted from the Omicron surge of COVID-19 during the quarter, I am pleased that we
were able to increase our Revenue by 8.0% and our Adjusted EBITDA<SUP>(1)</SUP> by 7.5% from last year&rsquo;s fourth quarter. This was
the result of ongoing strong demand for our services and the continuing migration of patient procedures from hospitals to free-standing
ambulatory outpatient imaging centers. The improvement in our operating metrics during the quarter overshadowed the negative impact from
the Omicron surge, which reduced our Revenue by over $4 million and our Adjusted EBITDA<SUP>(1)</SUP> by approximately $3 million in the
fourth quarter. The COVID-19 surge not only disrupted normal patient volumes, particularly in December, but also created staffing issues
at our facilities. At the height of the Omicron surge in December, we had 565 employees out on COVID leave, representing 6.3% of our entire
work force. I am pleased to report that currently the percentage of our employee base out with COVID-19 has decreased to 1.2% and patient
volume is returning to normalized levels.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Throughout the fourth quarter, we continued
to successfully manage our liquidity and financial leverage, while we made important investments to differentiate our facilities from
those of our competition. At year-end 2021, we had a cash balance of over $134 million and our net debt leverage ratio remained under
3.0 times Adjusted EBITDA<SUP>(1)</SUP>. Our Days Sales Outstanding (DSOs) at December 31, 2021 was 34.0 days, the lowest in our Company&rsquo;s
history. The improvement in revenue cycle operations and collections has materially contributed to our ability to manage the challenges
presented by COVID-19 and to make important investments for our future,&rdquo; Dr. Berger noted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Moving into 2022, the demand for diagnostic
imaging remains robust and is growing. Our strong financial position and operating model has presented us with targeted opportunities
to expand our business, particularly through the construction of new centers to meet the growing demand and utilization in strategic markets.
Currently, we have 15 new sites in various stages of construction and development, with almost half of this expansion occurring within
existing health system joint ventures. We believe these sites should be positive contributors to our performance in the second half of
2022 and throughout 2023,&rdquo; added Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger concluded, &ldquo;Subsequent to the
end of the fourth quarter of 2021, we completed the acquisitions of Aidence Holding B.V. and Quantib B.V., two Netherlands-based Artificial
Intelligence (&ldquo;AI&rdquo;) companies focused on creating population health screening tools primarily for lung cancer and prostate
cancer, respectively. During 2022, we will continue to develop the technical offerings and commercial expansion of these two businesses,
along with that of our DeepHealth&rsquo;s breast cancer AI screening algorithms. Though we have budgeted losses from these businesses
in 2022, we expect that they will be important to the growth and development of our network screening and population health strategies
in 2023 and beyond.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2021, RadNet reported
Revenue of $333.2 million and Adjusted EBITDA<SUP>(1)</SUP> of $54.5 million. Revenue increased $24.6 million (or 8.0%) and Adjusted EBITDA<SUP>(1)</SUP>
increased $3.8 million (or 7.5%) from the fourth quarter of 2020. Adjusted to remove $2.8 million of provider relief funding under the
CARES Act, Adjusted EBITDA<SUP>(1)</SUP> was $51.7 million during the fourth quarter, an increase of 2.0% from the fourth quarter of 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted Diluted Net Income Attributable to RadNet,
Inc. Common Stockholders (Adjusted Net Income<SUP>(3)</SUP>) for the fourth quarter of 2021 was $6.9 million, or $0.13 per diluted share
(&ldquo;Adjusted Earnings Per Share&rdquo;) as compared with $10.2 million, or $0.20 per diluted share for the same period in 2020. The
decrease in Adjusted Net Income and Adjusted Earnings Per Share is primarily the result of an increase in depreciation and amortization
expense, non-cash stock compensation expense and the fully diluted share count in the fourth quarter of 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unadjusted for unusual or one-time items in the
quarter, Net Income (Loss) Attributable to RadNet, Inc. Common Shareholders (&ldquo;Net Income&rdquo; or &ldquo;Net Loss&rdquo;) for the
fourth quarter of 2021 was $(3.8) million, or $(0.07) per diluted share. This compares to Net Income of $6.0 million, or $0.11 per diluted
share, in the fourth quarter of 2020. These per share values are based upon weighted average number of diluted shares outstanding of 54.0
million in the fourth quarter of 2021 and 52.2 million in the fourth quarter of 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the provider relief funding under
the CARES Act, affecting Net Income in the fourth quarter of 2021 were certain non-cash expenses or non-recurring items including: $3.6
million of non-cash employee stock compensation expense; $29,000 of severance paid in connection with headcount reductions related to
cost savings initiatives; $1.5 million loss on the disposal of certain capital equipment; $7.5 million of non-cash gain from interest
rate swaps; $831,000 legal settlement; $1.2 million transaction costs associated with completing the Aidence Holding B.V. and Quantib
B.V. acquisitions; $646,000 of amortization of deferred financing costs and loan discount related to our existing credit facilities; and
$19.7 million loss from abandoning certain leases related to facility closures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2021, as compared with
the prior year&rsquo;s fourth quarter, MRI volume increased 13.8%, CT volume increased 10.7% and PET/CT volume was flat. Overall volume,
taking into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 11.4% over the prior
year&rsquo;s fourth quarter. On a same-center basis, including only those centers which were part of RadNet for both the fourth quarters
of 2021 and 2020, MRI volume increased 8.0%, CT volume increased 6.6% and PET/CT volume decreased 0.4%. Overall same-center volume, taking
into account routine imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 7.3% from the prior year&rsquo;s
same quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Annual Report:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For full year 2021, RadNet reported Revenue of
$1,315.1 million and Adjusted EBITDA<SUP>(1)</SUP> of $218.9 million (inclusive of $9.1 million benefit from provider relief funding and
$7.7 million of benefit from the employee retention credit). Revenue increased $243.2 million (or 22.7%) and Adjusted EBITDA<SUP>(1)</SUP>
increased $79.5 million (or 57.0%) as compared with 2020. Adjusting to exclude the provider relief funding and employee retention credit
under the CARES Act, Adjusted EBITDA<SUP>(1)</SUP> was $202.1 million, an increase of $62.7 (or 44.9%) as compared with 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net Income for 2021 was $24.7 million, or $0.46
per diluted share. This compares to Net Loss of $14.8 million, or $(0.29) per diluted share, in 2020. These per share values are based
upon weighted average number of diluted shares outstanding of 53.4 million in 2021 and 50.9 million in 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the provider relief funding and
employee retention credit under the CARES Act, affecting Net Income for 2021 were certain non-cash expenses or non-recurring items including:
$25.2 million of non-cash employee stock compensation expense; $744,000 of severance paid in connection with headcount reductions related
to cost savings initiatives; $1.2 loss on the disposal of certain capital equipment; $6.0 loss on extinguishment of debt and related expenses
in conjunction with our debt refinancing transaction in April; $21.7 million of non-cash gain from interest rate swaps; $831,000 legal
settlement; $1.2 million transaction costs associated with completing the Aidence Holding B.V. and Quantib B.V. acquisitions; $3.3 million
of amortization of deferred financing costs and loan discount related to our existing credit facilities; and $19.7 million loss from abandoning
certain leases related to facilities closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year ended December 31, 2021, as compared
to 2020, MRI volume increased 26.2%, CT volume increased 21.9% and PET/CT increased 8.6%. Overall volume, taking into account routine
imaging exams, inclusive of x-ray, ultrasound, mammography and other exams, increased 25.2% for the twelve months of 2021 over 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Actual 2021 Results vs. 2021 Guidance:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following compares the Company&rsquo;s 2021
performance with previously announced revised guidance levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Original
Guidance<BR>
 Range</TD><TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">Revised Guidance <BR>
Range After Q3 <BR>
Results</TD><TD STYLE="padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center">2021 Actual Results</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 23%; text-align: justify">Total Net Revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 23%; text-align: justify">$1,250 - $1,300 million</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 23%">$1,300 - $1,350 million</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 23%">$1,315.1 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Adjusted EBITDA<SUP>(1)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$180 - $190 million</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$210 - $220 million</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$218.9 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Capital Expenditures<SUP>(a)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$70 - $75 million</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$85 - $90 million</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$98.8 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Cash Paid for Interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$39 - $44 million</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$35 - $40 million</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$29.0 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Free Cash Flow <SUP>(b)(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$60 - $70 million</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$80 - $90 million</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$91.1 million</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Net of proceeds from the sale of equipment, imaging centers and joint venture interests, and excludes
New Jersey Imaging Network capital expenditures of $12.4 million and the opportunistic purchase of $26.0 in the fourth quarter of equipment
that were on operating leases from certain OEM lessors.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Defined by the Company as Adjusted EBITDA</FONT><SUP>(1)</SUP> <FONT STYLE="font-size: 10pt">less
Capital Expenditures and Cash Paid for Interest. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger commented, &ldquo;We finished 2021
within our revised Revenue guidance range and close to the high end of our revised Adjusted EBITDA<SUP>(1)</SUP> range, ranges we increased
from our initial guidance levels throughout 2021. Our Free Cash Flow <SUP>(2)</SUP> results slightly exceeded our revised guidance range
as a result of our strong Adjusted EBITDA<SUP>(1)</SUP> performance and lower than anticipated cash interest expense, driven by our debt
refinancing transaction in April. Our capital expenditures exceeded our revised guidance range primarily as a result of the construction
of certain de novo locations that are expected to be operational in 2022.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>2022 Fiscal Year Guidance</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For its 2022 fiscal year, RadNet announces its
guidance ranges as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%">
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%; text-align: justify">Total Net Revenue</TD><TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 40%; text-align: justify">$1,350 million - $1,400 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA<SUP>(1)</SUP> Excluding Anticipated Losses</P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">from Artificial Intelligence Businesses</P></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$205 million - $215 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Capital Expenditures <SUP>(a)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$85 million - $90 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Cash Paid for Interest <SUP>(c)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$27 million - $32 million</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Free Cash Flow Generation <SUP>(b)(2)</SUP></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">$80 million - $90 million</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(a)</TD><TD STYLE="text-align: justify">Net of proceeds from the sale of equipment, imaging centers and joint venture interests, and excludes
New Jersey Imaging Network capital expenditures.</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(b)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Defined by the Company as Adjusted EBITDA</FONT><SUP>(1)</SUP> <FONT STYLE="font-size: 10pt">less
Capital Expenditures and Cash Paid for Interest.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(c)</TD><TD STYLE="text-align: justify">Excludes payments to counterparties on interest rate swaps.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger noted, &ldquo;It is important to understand
that our 2021 Adjusted EBITDA<SUP>(1)</SUP> was positively impacted by $9.1 million of provider relief proceeds and $7.7 million of employee
retention credit under the CARES Provider Relief Act. Additionally, we are estimating an impact of $7.4 million of Medicare reimbursement
reductions for 2022, based upon Medicare&rsquo;s final rule released in November. Removing these three items from 2021 Adjusted EBITDA<SUP>(1)</SUP>,
including the Medicare rate cuts as if they had existed at the beginning of 2021, the Adjusted EBITDA<SUP>(1)</SUP> to which we compare
our 2022 guidance is $194.7 million. The anticipated growth built into our guidance in 2022 from this value to our 2022 Adjusted EBITDA<SUP>(1)</SUP>
guidance range of $205 million to $215 million is projected to come from same-center growth, reimbursement increases from private and
capitated payers, new and expanded health system joint ventures and the contribution from acquisitions completed at various times in 2021.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Berger continued, &ldquo;For conservatism,
we have not included any new acquisitions or new health system joint ventures during 2022 into our guidance, and we have included approximately
$15 million of additional salaries and wages expense as a result of operating in a tighter labor market, where it has become more expensive
to attract and retain talent at all levels. We think our guidance has room for us to outperform, subject to the risks and uncertainties
of a continuing COVID-19 environment, and we look forward to providing updates to this guidance as we progress through the year.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&ldquo;Also, note that our Adjusted EBITDA<SUP>(1)</SUP>
guidance for 2022 excludes anticipated losses from our AI division (DeepHealth, Aidence and Quantib) of $12 million to $17 million, a
range which is impacted by the timing of certain FDA approvals and the resulting commercialization of various product offerings. We will
endeavor to report the losses in these businesses separately each quarter throughout 2022, providing transparency of the performance of
our core imaging business and allowing our stakeholders to track our progress in AI throughout the year,&rdquo; concluded Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Conference Call for Today</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger, President and Chief Executive
Officer, and Mark Stolper, Executive Vice President and Chief Financial Officer, will host a conference call today, at 10:30 a.m. Eastern
Time. During the call, management will discuss the Company's 2021 fourth quarter and year-end results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Conference Call Details:</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Date: Tuesday, March 1, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Time: 10:30 a.m. ET</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dial In-Number: 888-254-3590</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">International Dial-In Number: 929-477-0402</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 10pt">There will also be simultaneous and archived
webcasts available at </FONT>https://viavid.webcasts.com/starthere.jsp?ei=1532554&amp;tp_key=cca2370690 <FONT STYLE="font-size: 10pt">or
http://www.radnet.com under the &ldquo;About RadNet&rdquo; menu section and &ldquo;News &amp; Press Releases&rdquo; sub-menu of the website.
An archived replay of the call will also be available and can be accessed by dialing 844-512-2921 from the U.S., or 412-317-6671 for international
callers, and using the passcode 8161927.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>About RadNet, Inc.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RadNet, Inc. is the leading national provider of freestanding, fixed-site
diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based
on the number of locations and annual imaging revenue. RadNet has a network of 347 owned and/or operated outpatient imaging centers. RadNet's
markets include California, Maryland, Delaware, New Jersey, New York, Florida and Arizona. Together with affiliated radiologists, and
inclusive of full-time and per diem employees and technicians, RadNet has a total of approximately 9,000 employees. For more information,
visit http://www.radnet.com.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify"><B><I>Forward Looking Statements</I></B></P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">This press release contains &ldquo;forward-looking
statements&rdquo; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking
statements are expressions of our current beliefs, expectations and assumptions regarding the future of our business, future plans and
strategies, projections, and anticipated future conditions, events and trends. Forward-looking statements can generally be identified
by words such as: &ldquo;anticipate,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;goal,&rdquo; &ldquo;seek,&rdquo; &ldquo;believe,&rdquo;
&ldquo;project,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;strategy,&rdquo; &ldquo;future,&rdquo; &ldquo;likely,&rdquo;
&ldquo;may,&rdquo; &ldquo;should,&rdquo; &ldquo;will&rdquo; and similar references to future periods. Forward-looking statements in this
press release include, among others, statements we make regarding response to and the expected future impacts of COVID-19, including statements
about our anticipated business results, balance sheet and liquidity and our future liquidity, burn rate and our continuing ability to
service or refinance our current indebtedness.</P>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are neither historical
facts nor assurances of future performance. Because forward-looking statements relate to the future, they are inherently subject to uncertainties,
risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and
financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue
reliance on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to
differ materially from those indicated in the forward-looking statements include, among others, the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the ongoing impact of the COVID-19 pandemic on
our business, suppliers, payors, customers, referral sources, partners, patients and employees, including (i) government&rsquo;s unprecedented
action regarding existing and potential restrictions and/or obligations related to citizen and business activity to contain the virus;
(ii) the consequences of an economic downturn resulting from the impacts of COVID-19 and the possibility of a global economic recession;
(iii) the impact of the volume of canceled or rescheduled procedures, whether as a result of government action or patient choice; (iv)
measures we are taking to respond to the COVID-19 pandemic, including changes to business practices; (v) the impact of government and
administrative regulation, guidance and appropriations; (vi) changes in our revenues due to declining patient procedure volumes, changes
in payor mix; (vii) potential increased expenses or workforce disruptions related to our employees that could lead to unavailability of
key personnel; (viii) workforce disruptions related to our key partners, suppliers, vendors and others we do business with; (ix) the impact
of return to work orders in certain states in which we operate; and (x) increased credit and collectability risks;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital to fund
our business;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to service our indebtedness, make
principal and interest payments as those payments become due and remain in compliance with applicable debt covenants, in addition to our
ability to refinance such indebtedness on acceptable terms;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in general economic conditions nationally
and regionally in the markets in which we operate;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the availability and terms of capital to fund
the expansion of our business and improvements to our existing facilities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">our ability to maintain our current credit rating
and the impact on our funding costs and competitive position if we do not do so;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">volatility in interest and exchange rates, or
credit markets;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the adequacy of our cash flow and earnings to
fund our current and future operations;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">changes in service mix, revenue mix and procedure
volumes; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">delays in receiving payments for services provided;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">increased bankruptcies among our partner physicians
or joint venture partners;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the impact of the political environment and related
developments on the current healthcare marketplace and on our business, including with respect to the future of the Affordable Care Act;
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the extent to which the ongoing implementation
of healthcare reform, or changes in or new legislation, regulations or guidance, enforcement thereof by federal and state regulators or
related litigation result in a reduction in coverage or reimbursement rates for our services, or other material impacts to our business;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">closures or slowdowns and changes in labor costs
and labor difficulties, including stoppages affecting either our operations or our suppliers' abilities to deliver supplies needed in
our facilities;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the occurrence of hostilities, political instability
or catastrophic events; </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">the emergence or reemergence of and effects related
to future pandemics, epidemics and infectious diseases; and </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="margin-top: 0pt; font: 10pt Times New Roman, Times, Serif; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">noncompliance by us with any privacy or security
laws or any cybersecurity incident or other security breach by us or a third party involving the misappropriation, loss or other unauthorized
use or disclosure of confidential information.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any forward-looking statement contained in this
current report is based on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation
to publicly update any forward-looking statement, whether written or oral, that we may make from time to time, whether as a result of
changed circumstances, new information, future developments or otherwise, except as required by applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>Regulation G: GAAP and Non-GAAP Financial
Information</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This release contains certain financial information
not reported in accordance with GAAP. The Company uses both GAAP and non-GAAP metrics to measure its financial results. The Company believes
that, in addition to GAAP metrics, these non-GAAP metrics assist the Company in measuring its cash-based performance. The Company believes
this information is useful to investors and other interested parties because it removes unusual and nonrecurring charges that occur in
the affected period and provides a basis for measuring the Company's financial condition against other quarters. Such information should
not be considered as a substitute for any measures calculated in accordance with GAAP, and may not be comparable to other similarly titled
measures of other companies. Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial
information prepared in accordance with GAAP. Reconciliation of this information to the most comparable GAAP measures is included in this
release in the tables which follow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>CONTACTS: </I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>RadNet, Inc.</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Mark Stolper, 310-445-2800</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>Executive Vice President and Chief Financial
Officer</I></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONSOLIDATED BALANCE SHEETS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center">As of December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 66%; text-align: left">Cash and cash equivalents</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">134,606</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">102,018</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts receivable, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">135,062</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">129,585</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Due from affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,384</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,836</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">49,212</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">32,985</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">324,264</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">270,424</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Property and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">484,247</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">399,335</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Operating lease right-of-use assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">584,291</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">483,661</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total property, equipment and right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,068,538</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">882,996</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">OTHER ASSETS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">513,820</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">472,879</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Other intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">56,603</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,393</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Deferred financing costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,135</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,767</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Investment in joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">42,229</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,528</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Deferred tax assets, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,853</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">34,687</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Deposits and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,032</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,983</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,058,474</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,786,657</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: center">LIABILITIES AND EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">CURRENT LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable, accrued expenses and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">263,937</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">236,684</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Due to affiliates</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,530</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,010</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Deferred revenue related to software sales</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,701</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">39,257</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Current portion of finance lease</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,578</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Current portion of operating lease</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,452</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">65,794</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Current portion of notes payable and long term debt</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">11,164</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">39,791</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">374,784</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">398,114</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">LONG-TERM LIABILITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Finance lease, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">743</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Operating lease, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">577,675</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">463,096</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Notes payable, net of current portion</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">743,498</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">612,913</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Other non-current liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">16,360</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">53,488</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,712,317</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,528,354</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">RadNet, Inc. stockholders' equity:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; text-align: left">Common stock - $.0001 par value, 200,000,000 shares authorized; 53,548,227 and 51,640,537 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Additional paid-in-capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">342,592</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">307,788</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accumulated other comprehensive loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(20,421</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(24,051</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(93,272</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(117,999</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Total RadNet, Inc.'s stockholders' equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">228,904</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">165,743</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">117,253</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">92,560</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">346,157</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">258,303</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total liabilities and equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">2,058,474</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,786,657</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONSOLIDATED STATEMENTS OF OPERATIONS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center">Years Ended December 31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2021</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold">REVENUE</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; width: 49%; text-align: left">Service fee revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">1,166,743</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">931,722</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">1,028,236</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Revenue under capitation arrangements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">148,334</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">140,118</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">125,943</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 20pt; text-align: left">Total revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,315,077</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,071,840</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,154,179</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Provider relief funding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,110</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,264</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Cost of operations, excluding depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,123,274</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">965,902</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">999,692</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Lease abandonment charges</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,675</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96,694</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">86,795</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,607</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss on sale and disposal of equipment and other</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,246</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,383</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss on impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Severance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">744</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,353</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,619</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,241,633</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,062,420</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,084,301</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">INCOME FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">82,554</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,684</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">69,878</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,830</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,882</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,044</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,967</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,945</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,350</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,670</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,528</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Gain on re-measurement of pre-existing interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(768</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss (gain) on extinguishment of debt and related expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,044</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,047</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,438</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">120</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,283</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 1pt">Total other expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">23,675</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,538</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">40,209</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt">INCOME (LOSS) BEFORE INCOME TAXES</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">58,879</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(854</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">29,669</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(14,560</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(895</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(6,229</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET INCOME (LOSS)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44,319</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,749</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">23,440</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Net income attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">19,592</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">13,091</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">8,684</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">`</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">NET INCOME (LOSS) ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">24,727</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(14,840</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">14,756</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">BASIC NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.47</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.29</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.30</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">DILUTED NET INCOME (LOSS) PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.46</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.29</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.29</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">52,496,679</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,891,791</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">49,674,858</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">53,421,033</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,891,791</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,244,006</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">CONSOLIDATED STATEMENTS OF CASH FLOWS</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Years Ended December 31,</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: right; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">CASH FLOWS FROM OPERATING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; width: 49%; text-align: left">Net income (loss)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">44,319</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 13%; text-align: right">(1,749</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">23,440</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; text-align: left">Adjustments to reconcile net income&nbsp;to net cash provided by operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96,694</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">86,795</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">80,607</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Amortization of operating right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">73,967</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">67,915</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">66,842</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Lease abandonment charges</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,675</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(10,967</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,945</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,350</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Distributions from joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,707</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,522</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,598</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Amortization and write off of deferred financing costs and loan discount</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,254</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,413</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,184</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Loss on sale and disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,246</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,383</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Loss (gain) on extinguishment of debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,047</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Gain on re-measurement of pre-existing interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(768</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Loss on impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Amortization of cash flow hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,695</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,448</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Non-cash change in fair value of interest rate hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,670</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,528</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Stock-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,203</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,405</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8,730</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Other non cash item in other expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">242</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(371</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Change in value of contingent consideration</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,123</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; text-align: left">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Accounts receivable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,890</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,206</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(17,482</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Other current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(15,777</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,588</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,557</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Other assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">662</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,425</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,326</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Deferred taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,834</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(611</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,888</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Operating lease liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(72,553</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(53,906</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(66,831</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Deferred revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(28,319</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">37,941</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,082</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 30pt; text-align: left; padding-bottom: 1pt">Accounts payable, accrued expenses and other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">9,915</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">45,069</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,316</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by operating activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">149,491</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">233,759</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">104,322</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">CASH FLOWS FROM INVESTING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Purchase of imaging facilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(77,691</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(31,265</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(27,150</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Investment at cost</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(143</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Purchase of property and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(137,874</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(94,172</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(74,153</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Purchase of intangible assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(5,130</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Proceeds from sale of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">625</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">828</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,160</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Proceeds from sale of equity interest in a joint venture</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">132</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Nulogix return of capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">792</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Equity contributions in existing and purchase of interest in joint ventures</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,441</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(1,635</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(103</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(221,511</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(126,244</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(99,465</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">CASH FLOWS FROM FINANCING ACTIVITIES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Principal payments on notes and leases payable</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,302</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,562</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,494</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Payments on senior notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(619,529</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(43,296</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(40,742</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Additional deferred finance costs on revolving loan amendment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(938</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(741</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Proceeds from debt issuance, net of issuance costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">717,307</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">97,144</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Proceeds from Payment Protection Program</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,023</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Distributions paid to noncontrolling interests</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,426</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,985</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,057</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Proceeds from sale of noncontrolling interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,073</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,275</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Contributions from noncontrolling partners</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">750</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Proceeds from revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">128,300</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">250,900</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">261,200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Payments on revolving credit facility</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(128,300</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(250,900</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(289,200</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left; padding-bottom: 1pt">Proceeds from issuance of common stock upon exercise of options</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">488</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">75</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 40pt; text-align: left; padding-bottom: 1pt">Net cash provided by (used in)&nbsp;&nbsp;financing activities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">104,673</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(45,561</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">24,951</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">EFFECT OF EXCHANGE RATE CHANGES ON CASH</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(65</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(101</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(32</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">NET INCREASE IN CASH AND CASH EQUIVALENTS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">32,588</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">61,853</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29,776</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 1pt">CASH AND CASH EQUIVALENTS, beginning of period</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">102,018</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">40,165</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,389</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH AND CASH EQUIVALENTS, end of period</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">134,606</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">102,018</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">40,165</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Cash paid during the period for interest</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">29,042</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">39,521</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">46,254</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-indent: -10pt; padding-left: 20pt; text-align: left">Cash paid during the period for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">1,950</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,069</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">5,884</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>RADNET, INC. AND SUBSIDIARIES</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>CONSOLIDATED STATEMENTS OF OPERATIONS </B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.4pt"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-weight: bold">Three Months Ended</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">December 31,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2021</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">REVENUE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; width: 66%; text-align: left">Service fee revenue</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">296,264</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 13%; text-align: right">271,530</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-align: left">Revenue under capitation arrangements</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,885</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">36,973</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left">Total revenue</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">333,150</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">308,503</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Provider relief funding</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,819</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OPERATING EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Cost of operations, excluding depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">284,667</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">257,808</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Lease abandonment charges</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,675-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,421</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,259</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss on sale and disposal of equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,524</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">657</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Loss on impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-align: left">Severance costs</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">29</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,706</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 20pt; text-align: left">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">331,316</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">287,599</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">INCOME FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,652</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,903</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">OTHER INCOME AND EXPENSES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Interest expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,801</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,439</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Equity in earnings of joint ventures</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,707</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,769</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 10pt; text-align: left">Non-cash change in swap valuation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,520</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,995</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt; text-align: left">Gain on extinguishment of debt and related expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,047</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-align: left">Other expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(261</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">367</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 20pt; text-align: left">Total other (income) expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,312</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,996</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">INCOME BEFORE INCOME TAXES</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,340</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,908</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-align: left">(Provision for) benefit from income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,027</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(5,925</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">NET INCOME</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,313</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,983</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 1pt; padding-left: 10pt; text-align: left">Net income attributable to noncontrolling interests</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,137</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,028</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCK HOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(3,823</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">5,955</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON
    STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.07</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.12</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left"></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt; font-weight: bold; text-align: left">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.07</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.11</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt">Basic</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">53,046,347</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">51,384,586</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-bottom: 2.5pt; padding-left: 10pt">Diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">53,964,751</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">52,224,090</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC.</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RECONCILIATION OF GAAP NET INCOME ATTRIBUTABLE TO RADNET, INC. COMMON SHAREHOLDERS TO ADJUSTED EBITDA<FONT STYLE="font: normal 700 10pt Times New Roman, Times, Serif"><SUP>(1)</SUP></FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center"></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center">Three Months Ended <BR> December 31,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left">Net Income Attributable to RadNet, Inc. Common Stockholders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(3,823</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">5,955</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Provision for Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,027</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,925</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,801</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,439</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Severance Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,706</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Depreciation and Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,421</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">22,259</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Non Cash Employee Stock Based Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,637</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,260</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Loss on Sale and Disposal of Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,524</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">657</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Other Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(261</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">367</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Non Cash (Gain) in Fair Value of Interest Rate Hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,520</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,995</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Loss on Impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus (Gain) on Extinguishment of Debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,047</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Legal Settlement and Relate Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">831</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Lease Abandonment Charges</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,675</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Plus Transaction Costs - Aidence Holdings B.V. and Quantib B.V.</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,171</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><B>Adjusted EBITDA (1)</B></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">54,512</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">50,696</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; text-align: center"></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center">Fiscal Year Ended <BR> December 31,</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; text-align: center">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 70%; text-align: left">Net Income (Loss) Attributable to RadNet, Inc. Common Stockholders</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">24,727</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 11%; text-align: right">(14,840</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Provision for Income Taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,560</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">895</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Interest Expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">48,830</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">45,882</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Severance Costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">744</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,353</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Depreciation and Amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96,694</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">86,795</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Non Cash Employee Stock Based Compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,203</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,405</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Loss on Sale and Disposal of Equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,246</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,200</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Other Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,438</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">120</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Non Cash Loss in Fair Value of Interest Rate Hedge</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(21,670</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,528</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Loss on Impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Legal Settlement and Relate Expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">831</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus (Gain) on Extinguishment of Debt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,044</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(4,047</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Plus Lease Abandonment Charges</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,675</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Plus Transaction Costs - Aidence Holdings B.V. and Quantib B.V.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,171</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Less Other Adjustment to Joint Venture Investments</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(565</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt"><B>Adjusted EBITDA (1)</B></TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">218,928</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">139,461</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET, INC. AND SUBSIDIARIES</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">SCHEDULE OF ADJUSTED EARNINGS AND EARNINGS PER SHARE <FONT STYLE="font: normal 700 10pt Times New Roman, Times, Serif"><SUP>(3)</SUP></FONT></P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(IN THOUSANDS EXCEPT SHARE DATA)</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(unaudited)</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-weight: bold; text-align: center"></TD><TD>&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center"><B>Three Months Ended</B></TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center"></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; text-align: center"><B>December 31,</B></TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 66%; font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">COMMON STOCKHOLDERS</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 13%; border-bottom: Black 2.5pt double; text-align: right">(3,823</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="width: 2%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 13%; border-bottom: Black 2.5pt double; text-align: right">5,955</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Add severance costs</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">29</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,706</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Add loss on lease abondonment/impairment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,675</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,170</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Add legal settlement and related expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">831</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 10pt">Add transaction costs Aidence Holdings B.V. &amp; Quantib B.V.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,171</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&ndash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 10pt">Subtract non-cash gain on swap valuation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,520</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,995</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Subtract gain on extinguishment of debt</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(4,047</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 20pt">Total adjustments - loss (gain)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">14,186</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">834</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Subtract tax impact of Adjustments (i)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,508</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">217</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-left: 20pt">Tax effected impact of adjustments</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,678</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">617</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">Add non-recurring tax adjustment related to joint venture</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&ndash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3,639</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; padding-left: 10pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">TOTAL ADJUSTMENT TO NET INCOME ATTRIBUTABLE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 1pt; padding-left: 10pt">TO RADNET, INC. COMMON SHAREHOLDERS</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,678</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,256</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt">ADJUSTED NET INCOME ATTRIBUTABLE TO RADNET, INC.</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">6,855</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">10,211</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt">COMMON STOCKHOLDERS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-left: 10pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold">WEIGHTED AVERAGE SHARES OUTSTANDING</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="padding-left: 10pt">Diluted</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">53,964,751</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">52,224,090</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: left">ADJUSTED DILUTED NET INCOME PER SHARE</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="font-weight: bold; text-align: left; padding-bottom: 2.5pt; padding-left: 10pt">ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.13</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">0.20</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">(i) Tax effected using 26.00% and 24.73% blended
federal and state effective tax rate for 2020 and 2021, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">PAYOR CLASS BREAKDOWN&nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 58%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"></TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Fourth Quarter</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 43%; text-align: left">Commercial Insurance</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">57.8%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicare</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21.9%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Capitation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11.1%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Medicaid</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2.6%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Workers Compensation/Personal Injury</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.5%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">3.1%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Total</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">RADNET PAYMENTS BY MODALITY</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">  &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center"></TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Fourth Quarter</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">Full Year</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2021</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2020</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; border-bottom: Black 1pt solid">2019</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="width: 40%">MRI</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.9%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">36.0%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.4%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">35.8%</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.9%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.2%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.9%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>PET/CT</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.5%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.6%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>X-ray</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3.9%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8.1%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD>Ultrasound</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.6%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.7%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.3%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.4%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Mammography</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16.1%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.7%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">15.2%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">Nuclear Medicine</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.0%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1pt">Other</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.6%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.6%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.7%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4.9%</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(238,238,238)">
    <TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">100.0%</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Footnotes</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>&nbsp;</SUP></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(1)</SUP> The Company defines Adjusted EBITDA
as earnings before interest, taxes, depreciation and amortization, each from continuing operations and excludes losses or gains on the
disposal of equipment, other income or loss, loss on debt extinguishments, bargain purchase gains and non-cash equity compensation. Adjusted
EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries,
and is adjusted for non-cash and extraordinary events which took place during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted EBITDA is reconciled to its nearest comparable
GAAP financial measure. Adjusted EBITDA is a non-GAAP financial measure used as analytical indicator by RadNet management and the healthcare
industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not
be considered a measure of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation
or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a
measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented,
may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(2)</SUP> As noted above, the Company defines
Free Cash Flow as Adjusted EBITDA less total Capital Expenditures (whether completed with cash or financed) and Cash Interest paid. Free
Cash Flow is a non-GAAP financial measure. The Company uses Free Cash Flow because the Company believes it provides useful information
for investors and management because it measures our capacity to generate cash from our operating activities. Free Cash Flow does not
represent total cash flow since it does not include the cash flows generated by or used in financing activities. In addition, our definition
of Free Cash Flow may differ from definitions used by other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Free Cash Flow should not be considered a measure
of financial performance under GAAP, and the items excluded from Adjusted EBITDA should not be considered in isolation or as alternatives
to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the
consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted EBITDA is not a measurement determined
in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as presented, may not be comparable
to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><SUP>(3)</SUP> The Company defines Adjusted Earnings
Per Share as net income or loss attributable to RadNet, Inc. common stockholders and excludes losses or gains on the disposal of equipment,
loss on debt extinguishments, bargain purchase gains, severance costs, loss on impairment, loss or gain on swap valuation, gain on extinguishment
of debt, unusual or non-recurring entries that impact the Company&rsquo;s tax provision and any other non-recurring or unusual transactions
recorded during the period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted Earnings Per Share is reconciled to its
nearest comparable GAAP financial measure. Adjusted Earnings Per Share is a non-GAAP financial measure used as analytical indicator by
RadNet management and the healthcare industry to assess business performance. Adjusted Earnings Per Share should not be considered a measure
of financial performance under GAAP, and the items excluded from Adjusted Earnings Per Share should not be considered in isolation or
as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data
presented in the consolidated financial statements as an indicator of financial performance or liquidity. As Adjusted Earnings Per Share
is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation, this metric, as
presented, may not be comparable to other similarly titled measures of other companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>radnet_ex9902.htm
<DESCRIPTION>TRANSCRIPT OF CONFERENCE CALL
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.2</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">RadNet, Inc. Fourth Quarter and Full-Year 2021
Financial Results Call 8161927 2022/03/01</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good day, ladies and gentlemen, and welcome to
the RadNet, Inc. Fourth Quarter and Full-Year 2021 Financial Results Call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Today's conference is being recorded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to turn the conference
over to Mr. Mark Stolper, Executive Vice President and Chief Financial Officer of RadNet, Inc. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mark Stolper</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you. Good morning, ladies and gentlemen,
and thank you for joining Dr. Howard Berger and me today to discuss RadNet's Fourth Quarter and Full-Year 2021 Financial Results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we begin today, we'd like to remind everyone
of the Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. This presentation contains forward-looking statements
within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning anticipated future
financial and operating performance, RadNet's ability to continue to grow the business by generating patient referrals and contracts with
radiology practices, recruiting and retaining technologists, receiving third-part reimbursement for diagnostic imaging services, successfully
integrating acquired operations, generating revenue and Adjusted EBITDA for the acquired operations as estimated, among others, are forward-looking
statements within the meaning of the Safe Harbor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Forward-looking statements are based on Management's
current preliminary expectations and are subject to risks and uncertainties which may cause RadNet's actual results to differ materially
from the statements contained herein. These risks and uncertainties include those risks set forth in RadNet's reports filed with the SEC
from time to time, including RadNet's Annual Report on Form 10-K for the year ended December 31, 2021 to be filed shortly. Undue reliance
should not be placed on forward-looking statements, especially guidance on future financial performance which speaks only as of the date
it is made. RadNet undertakes no obligation to update publicly any forward-looking statements to reflect new information, events, or circumstances
after the date they were made, or to reflect the occurrence of unanticipated events.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that, I'd like to turn the call back over
to Dr. Berger.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark. Good morning, everyone, and thank
you for joining us today.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On today's call, Mark and I plan to provide you
with highlights from our fourth quarter and full-year 2021 results, give you more insight into the factors which affected this performance
and discuss our future strategy. After our prepared remarks, we will open the call to your questions. I'd like to thank all of you for
your interest in our Company and for dedicating a portion of your day to participate in our conference call this morning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Before we start, I would like to say on behalf
of myself and the entire team at RadNet, we hope all of you and your loved ones are healthy and staying safe. We are extremely grateful
for all of our stakeholders including our employees, business partners, lenders and shareholders and wish you all well during these challenging
times.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Let's begin. Despite being impacted by the recent
Omicron surge of COVID-19, particularly late in the fourth quarter, I am very pleased with our performance in the fourth quarter. We were
able to increase our revenue by 8% and our Adjusted EBITDA by 7.5% from last year's fourth quarter. The improvement with the result of
ongoing strong demand for our services and the continuing migration of patient procedures from hospitals to freestanding ambulatory outpatient
imaging centers. The strong demand for our services was enough to overcome the negative impact from the surge, which reduced our fourth
quarter revenue by over $4 million and our Adjusted EBITDA by approximately $3 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The COVID-19 surge not only disrupted normal patient
volumes but also created staffing issues at our facilities. At the height of the Omicron surge, in December, we had 565 employees out
on COVID leave representing 6.3% of our entire workforce. I am pleased to report that after peaking in the first week of January where
we had 8.2% of our staff out on COVID leave, or 743 employees, currently the percentage of our employee base out with COVID-19 has decreased
to 1.2%.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, the slowdown in COVID cases has
patient volume returning to more normalized levels. This gave us the optimism that is embedded in our 2022 guidance levels which Mark
will review in detail in his prepared remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consistent with our efforts throughout the pandemic,
during the fourth quarter, we continued to focus on strengthening our balance sheet by managing our liquidity and financial leverage.
We accomplished this while still making important investments in our facilities, equipment and technology. At the year-end 2021, we had
a cash balance of over $134 million and a net leverage ratio of 2.9 times Adjusted EBITDA. Our days sales outstanding, or DSOs, at December
31, 2021 was 34.0 days, the lowest in our Company's history.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The improvement in revenue cycle operations and
collections has materially contributed to our ability to manage the challenges presented by COVID-19 and to make important investments
for our future. We are particularly pleased with our liquidity position given that we repaid over $50 million of COVID-19 related deferrals
throughout 2021, which included Medicare and Blue Shield of California advanced payments, payroll taxes under federal assistance programs
and cash flow concessions we received from landlords of our facilities. Currently, we only have $8 million of deferrals left to repay
during 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are extremely appreciative of the cash flow
assistance we received from these government organizations and business partners during the global pandemic and we are gratified that
we've been able to repay these deferrals so quickly. We believe that our strong balance sheet position allows us to be aggressive in 2022
with respect to growth initiatives which will include tuck-in acquisitions, de novo centers and continued capital spending to drive same-center
performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I'd like reflect on some of our achievements throughout
2021, which further our long-term operating plan. Here are some of the highlights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">First, throughout 2021, we focused on improving
clinical operations to drive same-center growth and to efficiently manage our capacity to service the recovering demand for diagnostic
imaging as the country began to move past COVID-19. We consolidated centers, centralized certain support functions and improved clinical
protocols to drive efficiencies and capacity utilization. We drove reimbursement increases from private and capitated payors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also made important investments in equipment
and improved our throughout and accuracy. We completed our system-wide adoption of 3D mammography and piloted technologies to make MRI
scans shorter for our patients and to allow technologists to remotely control equipment in multiple locations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We also completed a number of tuck-in acquisitions
throughout many of our core markets and were successful in expanding several of our health system joint ventures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With respect to our DeepHealth AI division, we
received FDA clearance of the DeepHealth Sage-Q mammography workflow triage (inaudible) in April of last year. We integrated this powerful
AI tool within many of our contracted radiology groups throughout the remainder of the year. In 2021, DeepHealth also prepared and filed
an FDA submission for its more advanced AI tool, Sage-Dx, which was submitted to the FDA in early January of this year. We expect to receive
clearance sometime during the second quarter for this algorithm, which we believe will be integral in our population health and cancer
screening strategy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also in 2021, we began to execute on our vision
to create a suite of AI enhanced diagnostic imaging screening tools for the most prevalent cancers. We believe large scale cancer screening
will be an important part of future population health management. We formulated our interest in moving beyond DeepHealth's current focus
of breast cancer towards securing screening algorithms for lung, prostate and colon cancer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During 2021, we identified two companies to acquire
to address opportunities in lung and prostate cancer screening - Aidence Holding B.V. and Quantib B.V. acquisitions were completed in
January of this year. Aidence's artificial intelligence for chest and lung CT scanning is currently used by customers in seven European
countries and its leading product is pending FDA approval for use in the United States. With customers in 20 countries worldwide, Quantib
solutions prostate and brain MRI already have FDA 510(k) clearance in the United States and CE Mark in Europe. Aidence and Quantib have
joined DeepHealth in our AI division led by Dr. Gregory Sorenson, who has assumed responsibility for all of RadNet's AI initiatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Finally, in April of 2021, we completed the refinancing
of our term loan and revolving line of credit. Based upon current leverage ratios, we are saving approximately $6 million annually in
our interest expense as compared with our prior debt facilities. Additionally, we no longer are subject to restrictive maintenance covenants
with respect to our term loan and have substantially more operating and financial flexibility under the new credit agreement. This includes
lowering our annual required amortization payments by over $30 million, providing us with more cash flow to invest in further growth and
development.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to turn the call back over
to Mark to discuss some of the highlights of our fourth quarter and full-year 2021 performance, as well as discuss in detail our guidance
levels for 2022. When he is finished, I will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mark Stolper</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Howard.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I'm now going to briefly review our fourth quarter
and full-year 2021 performance and attempt to highlight what I believe to be some material items. I will also give some further explanation
of certain items in our financial statements as well as provide some insights into some of the metrics that drove our fourth quarter and
full-year 2021 performance. I will also provide 2022 financial guidance levels, which were released in this morning's financial results
press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In my discussion, I will use the term Adjusted
EBITDA which is a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and
amortization and excludes losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishments and non-equity
compensation -- non-cash equity compensation. Adjusted EBITDA includes earnings in unconsolidated operations and then subtracts allocations
of earnings to non-controlling interest in subsidiaries and is adjusted for non-cash or extraordinary and one-time events taking place
during the period. A full quantitative reconciliation of Adjusted EBITDA to net income or loss attributable to RadNet, Inc. common shares
is included in our earnings release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With that siad, I'd now like to review our fourth
quarter and full-year 2021 results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2021, RadNet reported
revenue of $333.2 million and Adjusted EBITDA of $54.5 million. Revenue increased $24.6 million or 8% and Adjusted EBITDA increased $3.8
million or 7.5% from the fourth quarter of 2020. Adjusted to remove $2.8 million of provider relief funding under the CARES Act, Adjusted
EBITDA was $51.7 million during the fourth quarter, an increase of 2% from the fourth quarter of 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As Dr. Berger mentioned in his opening remarks,
the strong demand for our services was enough to overcome the negative impact from the Omicron surge, which reduced our revenue by over
$4 million and our Adjusted EBITDA by approximately $3 million in the fourth quarter. The COVID-19 surge not only disrupted normal patient
volumes but also created staffing issues at our facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the fourth quarter of 2021, as compared with
the prior year's fourth quarter, MRI volume increased 13.8%, CT volume increased 10.7% and PET/CT volume was flat. Overall volume, taking
into account routine imaging exams inclusive of x-ray, ultrasound, mammography and all other exams, increased 11.4% over the prior year's
fourth quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the fourth quarter of 2021, we performed 2,201,920
total procedures. The procedures were consistent with our multimodality approach whereby 76.5% of all the work we did by volume was from
routine imaging. Our procedures in the fourth quarter of 2021 were as follows: 314,682 MRIs as compared with 276,482 MRIs in the fourth
quarter of 2020; 191,180 CTs as compared with 172,728 CTs in the fourth quarter of 2020; 11,066 PET/CTs as compared with 11,063 PET/CTs
in the fourth quarter of 2020; and 1,684,992 routine imaging exams as compared with 1,516,813 routine imaging exams in the fourth quarter
of 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On a same-center basis, including only those centers
which were part of RadNet for both the fourth quarters of 2021 and 2020, MRI volume increased 8%; CT volume increased 6.6%; and PET/CT
volume decreased 0.4%. Overall same-center volume, taking into account routine imaging exams, increased 7.3% from the prior year's same
quarter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Adjusted net income, which is net income adjusted
for unusual or one-time items, was $6.9 million or $0.13 per diluted share as compared with $10.2 million or $0.20 per diluted share for
the same period in 2020. The decrease in adjusted net income and adjusted earnings per share is primarily the result of an increase in
depreciation and amortization expense, non-cash stock compensation expense and the fully diluted share count in the fourth quarter of
2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the $2.8 million of provider relief
funding under the CARES Act, affecting net income in the fourth quarter of 2021 were certain non-cash expenses or non-recurring items
including the following: $3.6 million of non-cash employee stock compensation expense; $29,000 of severance paid in connection with headcount
reductions related to cost savings initiatives; $1.5 million loss on the disposal of certain capital equipment; $7.5 million of non-cash
gain from interest rate swaps; $831,000 legal settlement; $1.2 million transaction cost associated with completing the Aidence Holding
B.V. and the Quantib B.V. acquisitions; $646,000 of amortization of deferred financing cost and loan discounts related to our existing
credit facilities; and $19.7 million loss from abandoning certain leases related to facility closures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to some specific income statement
accounts, overall GAAP interest expense for the fourth quarter of 2021 was $11.8 million. This compares with GAAP interest expense in
the fourth quarter of 2020 of $12.4 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash paid for interest during the period, which
excludes non-cash deferred financing expense, accrued interest and payments to swap counterparties, was $7.6 million as compared with
$8.3 million in the fourth quarter last year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For full-year 2021, RadNet reported $1,315,100,000
of revenue and Adjusted EBITDA of $218.9 million. This Adjusted EBITDA includes the benefits of $9.1 million of provider relief funding
and $7.7 million of employee retention credit under the CARES Provider Relief Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Revenue increased $243.2 million or 22.7% and
Adjusted EBITDA increased $79.5 million or 57% as compared with 2020. Adjusting to exclude the provider relief funding and the employee
retention credit, Adjusted EBITDA was $202.1 million, an increase of $62.7 million or 44.9% as compared with 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the year-ended December 31, 2020 as compared
to 2020, MRI volume increased 26.2%, CT volume increased 21.9%, and PET/CT volume increased 8.6%. Overall volume, taking into account
all routine imaging exams, increased 25.2% for the 12 months of 2021 over 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In 2021, we performed 8,598,593 total procedures.
The procedures were consistent with our multimodality approach whereby 76.3% of all the work we did by volume was for routine imaging.
Our procedures in 2021 are as follows: 1,232,427 MRIs as compared with 976,633 MRIs in 2020; 756,509 CTs as compared with 620,547 CTs
in 2020; 45,124 PET/CTs as compared with 41,567 PET/CTs in 2020; and 6,564,533 routine imaging exams as compared with 5,228,274 of all
these exams in 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Net income for 2021 was $24.7 million or $0.46
per diluted share. This compares to a net loss of $14.8 million or negative $0.29 per diluted share in 2020. These per share values are
based upon weighted average number of diluted shares outstanding of 53.4 million in 2021 and 50.9 million in 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to the provider relief funding and
employee retention credit under the CARES Act, affecting net income for 2021 were certain non-cash expenses or non-recurring items including
the following: $25.2 million of non-cash employee stock compensation expense; $744,000 of severance paid in connection with headcount
reductions related to cost savings initiatives; $1.2 million loss on the disposal of certain capital equipment; $6 million loss on the
extinguishment of debt and related expenses in conjunction with our debt refinancing transaction in April; $21.7 million of non-cash gain
from interest rate swaps; $831,000 of legal settlements; $1.2 million transaction cost associated with completing the Aidence Holding
B.V. and the Quantib B.V. acquisitions; $3.3 million of amortization of deferred financing cost and loan discount related to our existing
credit facilities; and $19.7 million loss from abandoning certain leases related to facilities closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to some specific income statement
accounts, overall GAAP interest expense in 2021 was $48.8 million. Adjusted for the impacts from items such as amortization of financing
fees, accrued interest and payments to swap counterparties, cash interest expense was $29 million in 2021. This compares with GAAP interest
expense in 2020 of $45.9 million in cash paid for interest of $39.5 million in 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">With regards to our balance sheet, as of December
31, 2021, unadjusted for bond and term loan discounts, we had $633.3 million of net debt, which is our total debt at par value less our
cash balance. Note that this debt balance includes the New Jersey Imaging Network's debt of approximately $46.5 million for which RadNet
is neither a borrower nor guarantor. This compares with $563.7 million of net debt at December 31, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of year-end 2021, we were undrawn on our $195
million revolving line of credit and had a cash balance of $134.6 million, which was substantially up from the $102 million cash balance
at year-end 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As Dr. Berger mentioned in his opening remarks,
our liquidity position is especially gratifying as we repaid during 2021 over $50 million of deferrals we had received from government
assistance programs, private payors and landlords.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At December 31, 2020, our accounts receivable
balance was $135.1 million, an increase of $5.5 million from year-end 2020. Our DSO was 34 days at December 31, 2021, lower by 2.2 days
when compared with the 36.2 days of DSOs one year earlier. The decrease in our DSO is mainly from improved cash collections, including
additional efforts and resources dedicated to patient collections at the time of service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Throughout 2021, we had total capital expenditures
net of asset dispositions and the sale of imaging center assets and joint venture interest of $98.8 million. This amount excludes $12.
4 million of capital expenditures of New York Imaging Network and the opportunistic purchase of $26 million in the fourth quarter of equipment
that were on operating leases from certain OEM lessors. Approximately all of our capital expenditures were paid for in cash and we recognized
$625,000 in proceeds from the sale of equipment. Capital expenditures in 2021 were higher than what we originally budgeted as a result
of the construction of certain de novo locations that are expected to be operational in 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At this time, I'd like to review our 2022 financial
guidance levels, which we related this morning in our financial results press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For total net revenue, our guidance range is $1.350
billion to $1.400 billion. For Adjusted EBITDA, which excludes anticipated losses from artificial intelligence businesses, the guidance
range is $205 million to $215 million. For capital expenditures, our guidance range is $85 million to $90 million. For cash paid for interest,
our guidance range is $27 million to $32 million. And finally, for free cash flow generation, our guidance level is $80 million to $90
million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">It's important to understand that our 2021 Adjusted
EBITDA results were positively impacted by $9.1 million of provider relief proceeds and $7.7 million of employee retention credit under
the CARES Provider Relief Act. Additionally, we are estimating an impact of $7.4 million of Medicare reimbursement reductions for 2022
based upon Medicare's final rule released in November. Adjusting 2021 Adjusted EBITDA for these three items, including the Medicare rate
cuts as if they had existed at the beginning of 2021, the Adjusted EBITDA to which we compare our 2022 guidance is $194.3 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The anticipated growth built into our guidance
in 2022 from this value to our Adjusted EBITDA guidance range of $205 million to $215 million is projected to come from same-center growth,
reimbursement increases from private and capitated payors, new and expanded health system joint ventures, and the contribution from acquisitions
completed at various times during 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For conservatism, we have not included any new
acquisitions or new health system joint ventures during 2022 into our guidance and we have included approximately $15 million of additional
salaries and wages in 2022 as a result of operating in a tighter labor market where it has become more expensive to attract and retain
talent at all levels.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We think our guidance has room for us to outperform,
subject, of course, to the risks and uncertainties of the continuing COVID environment, and look forward to providing updates to this
guidance as we progress throughout the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Also note that our Adjusted EBITDA guidance for
2022 excludes the anticipated losses from our AI division, which includes DeepHealth, Aidence and Quantib, of roughly $12 million to $17
million, a range which is impacted by the timing of certain FDA approvals and the resulting commercialization of various product offerings.
We will endeavor to report the losses in these businesses separately each quarter throughout 2022 providing transparency of the performance
of our core imaging business and allowing our stakeholders to track our progress in AI throughout the year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I'd now like to turn the call back to Dr. Berger
who will make some closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you, Mark.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Moving into 2022, the demand for diagnostic imaging
remains robust and is growing. Our strong financial position and operating model has presented us with targetted opportunities to expand
our business, particularly through the construction of new centers to meet the growing demand and utilization in strategic markets. Currently,
we have 15 new sites in various stages of construction and development with almost half of these expansions occurring within existing
health system joint ventures. These new sites are focused in areas where we currently are unable to meet the demand for services due to
capacity constraints or because we simply do not have locations overlapping significant patient populations that we or, in certain cases,
our hospital partners, have identified. We believe these denovo sites should be major contributors to our performance in the second half
of 2022 and throughout 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we now approach the end of the first quarter
of 2022, we are excited for the remainder of the year. Besides the construction and development of the centers I just mentioned, we expect
to make progress on a number of other fronts in 2022. We will continue to focus on driving same-center procedural and revenue growth,
while managing expenses carefully. We will advance current discussions with existing and new joint venture partners for establishing new
JVs and expanding existing ones. In our AI division, we will focus on getting successful clearances for DeepHealth's advanced mammography
algorithm and Aidence's lung CT technology. We will also continue to have discussions with large health plans, employer groups and capitated
payors about adopting large scale cancer screening programs driven by artificial intelligence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our strong cash position at the end of 2021 leading
into this year, along with the availability of a $195 million revolving credit facility, will provide us the financial flexibility and
capability to pursue accretive strategic acquisitions and execute on all other facets of our operating plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator, we are now ready for the question-and-answer
portion of the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We'll take our first question from Brian Tanquilut
with Jefferies. Plg.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brian Tanquilut</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hey guys. Good morning. I guess, Howard, my first
question for you. I've covered you guys for, gosh, 15 years now and this is the first time I think that I'm seeing you focused on denovos.
So, what was the impetus for that and anything you can share with us in terms of maybe what has changed in the market and that whole discussion
of buy versus build?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Good morning, Brian. Thank you for the question.
During the year, despite the challenges presented by COVID, we noticed that there was increasing demand for outpatient elective imaging
procedures, which we think is finally being substantially enhanced by the greater efforts that most of the major health payors are making
to direct business into lower cost outpatient imaging facilities. That alone with initiatives that we've undertaken, particularly in mammography
to improve compliance, has led to very impressive increase in volumes in our markets and where we realized that the only way for us to
really provide additional capacity is to build new imaging centers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, in our particular business model where we
have densely -- where we have many centers in densely populated markets, and where consolidation continues to occur, we are recognizing
that we cannot continue to just add pieces of equipment because we are space constrained and that some of the prospects that we have for
the future, particularly with artificial intelligence, which we believe will create greater demand for screening tools, not only in breast
cancer but in lung, prostate and colorectal cancer, which we will be aggressively pursuing, we need to prepare for the ability to manage
this increased demand. As a result, we've identified 15 new locations that we believe due to our backlogs, increasing demand and migration
away from hospital-based outpatient business into these imaging centers will create this need.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That is also something that we decided to embark
on as a result of the very high multiples that we see acquisitions being done generally inside the imaging center business. For us, and
I think it's unique to our business model and strategy, it becomes substantially more opportunistic for us to build it this time rather
than buy. As you know, Brian, over the years, and we still try to target acquisitions in the 3 to 6 times multiple of EBITDA, but given
the fact that most of the larger acquisitions that we're seeing are for multiples substantially high than that and that there's a decreasing
number of centers in our markets that are available for acquisition, the decision to create denovo centers really satisfies both the need
for demand as well as a more prudent use of our capital resources.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, this is, as I think you've noted astutely,
Brian, and because you've been following us so long, a change and it's a substantial change in, I believe, the perspective of how, at
least within our given markets, we need to be more judicious in our capital expenditures about creating additional capacities and opportunities
for growth. The leverage, if you will, for building a new center and having it become operationally in line with our revenue projections
will make these acquisitions of -- or not acquisitions, but the construction of these denovo centers for us less than a 5 times multiple
of their EBITDA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So I think we are being careful and responsible
in managing our cash flow and capital expenditures in a way that we think long term will be far more beneficial for the Company's strategic
purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Brian Tanquilut</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, that makes a lot of sense, Howard. I guess
my next question, as I think about your AI strategy and your big push into cancer, we've heard of the Cancer Moonshot being revived here.
Just want to hear your thoughts about it. I guess, taking it a step further, my understanding of your strategy, right, where you think
or you believe that your AI push into cancer will open the door for top line growth as more screening is encouraged by the payors. So
I guess, the question there is, how are those conversations going because obviously we've seen some of these efforts in the past, whether
it's CTs to replace colonoscopies or Cologuard, for that matter. Just curious how you're thinking the landscape will evolve where the
protocol becomes imaging for cancer screening instead of the existing protocols that are out there.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thanks, Brian. Another good question. If we take
a look down the road, which I believe now is a little clearer than it might have been a couple of years ago, there's a number of initiatives
which the Cancer Moonshot program has really highlighted. That is that technology has been a major driver in making cancer screening a
reality. What I mean by that are two things. Number one, as the equipment itself improves in both resolution and shortening scanning times
and making it a more cost-effective and better experience for our patients, the ability for us to do screening for breast, lung, prostate
and cancer now becomes a much more realistic financial or economic aspiration. What used to take us, for example, an MRI scanning for
doing a prostate MRI of half hour or more, and now with modified tools and other artificial intelligence which is embedded in the equipment
itself, allow us to reduce that scanning time to perhaps as little as five minutes. Therefore, we can bring down the cost of screening
for prostate into something more like what there is today for breast cancer screening using mammography.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Therein lies really the opportunity which artificial
intelligence adding that on, will do two things. Number one, will help identify cancers earlier than other tools, both inside and outside
imaging, and create greater accuracy. Not to mention that if these screening tools have the kind of adoption that we think is inevitable,
we're going to need artificial intelligence to help the demand to read and interpret all of these imaging procedures much more efficiently
than currently exists and in an environment where there's already a shortage of radiologist personnel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our need and responsibility, and which we think
if you read the White House's press release about reviving Cancer Moonshot, almost looks like it could have been something that we wrote
about cancer screening. When you talk about cancer screening, while we can talk about things like Cologuard or even some of these other
blood tests, they don't identify if they do see a high risk or potential for cancer, where that cancer is and which part of the body it
is. The only way we believe they have effective cancer screening is really through imaging protocols and particularly the four cancers
that I mentioned - breast, lung, prostate and colon - represent 70% of all solid tumors. So, we're talking about something which could
have a major impact on cancer, both in terms of screening people earlier and changing the curve, if you will, about morbidity and cost
for the system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our responsibility, as well as that of the government,
is really not just to put these tools in place, but to also get our patients and the population to come to these tools. So in regard to
I think what you're talking about, we see as part of our strategy here is not only bringing artificial intelligence to RadNet centers,
but working with other providers out there, other imaging centers, hospitals to provide cancer screening networks which we believe we
can be instrumental in making happen and create networks throughout the country that, along with helping create new tools or even plans
within the healthcare payors, to drive more and more people for compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, as we see, what we call our network strategy
in population health initiatives, we believe there will be opportunities to drive revenue into this Company that are capital light, if
you will, and at the same time help provide what is really necessary to get Cancer Moonshot off the ground.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So we're looking at this as not only a great opportunity
for RadNet, but more importantly a great opportunity for the healthcare industry and population health management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We'll take our next question from Sarah James
with Barclays. Please go ahead.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Steve Braun</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi guys. This is Steve Braun on for Sarah. I just
had a question...</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mark Stolper</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hi Steve.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Steve Braun</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Hey guys. Just had a question going back to the
priorities for capital deployment. I think last quarter it seems like you had highlighted fielding more inbound calls from payors to move
business away from traditional brick-and-mortar hospitals. I guess can you talk about how that's evolved up through the end of the year
and the beginning of the year? Also update us on the view for the JV strategy. As it relates to where you see it going as a percentage
of your imaging centers, do you still think that it could be half of imaging centers versus, I guess, it's roughly 25% or 30% in 3Q?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes. Thank you, Steve. Good morning. The change
that has occurred really is discussions that we're having with the payors in our various markets as to programs we can begin implementing
that will help direct patients into outpatient centers, and particularly RadNet centers. So this is the first time that we've really seen
a more aggressive effort on the part of the payors to do this. I believe that in large part, this may actually be occurring as an outgrowth
of COVID because more and more people are less inclined to go into a hospital environment because of the concerns that they have for COVID,
which are very likely to persist for a very long time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, I believe that has provided some additional
impetus to the payors to talk to us, given that our network strategy and our markets provides us with an enormous amount of access where
they can make substantial strides in. So while I can't necessarily quantify to what extent that has happened, we hope to be able to facilitate
that for the payors as well as our own centers here as we move into 2022 -- excuse me, past (phon) 2020/22.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So we're really having discussions that we really
never had before with virtually almost every major payor out there in terms of not only how we take business (inaudible) starting conversations
with them about screening technology and artificial intelligence to help further distinguish the outpatient ambulatory imaging center
marketplace versus the hospital. So, we think this is very much a shift in sentiment that we've seen starting in the second half of 2021
and with that we hope to have conversations about how the insurance company can actually change their plans in order to encourage more
business being directed into outpatient centers as well as more screening tools.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So, we're very confident that our same store center
growth, which generally we assume will be about 2% to 3%, could be significantly higher than that. But I think we have to wait through
the remainder of this year to see how much of that we really can realize. I will say that starting off this year, while January still
had a significant impact from the Omicron surge that spread from the second half into January, February volumes are very impressive and
I think are reflecting a number of the elements of shift of business into our centers, particularly on the East Coast here and virtually
every market that we're in.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I'm not sure I answered your second question,
Steve. If you want to repeat that for me?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Steve Braun</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, I guess, I was just looking to get to see
if the joint ventures with the hospital systems, are they roughly flat from 3Q at 25% to 30% or have they improved at all in 4Q?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, thank you for reminding me of that, Steve.
Yes, there is a slow shift where they were about 25% coming into 2021. They're now probably closer to 30%. We believe a number of initiatives
that we're working on and our goal is to be able to drive that number closer to 50% within the next couple of years. That will come from
both current centers that we have that we put in with some of our current joint venture partners</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, thank you for reminding me that, Steve. There
is a slow shift where they were about 25% coming into 2021. They're now probably closer to 30%. We believe a number of initiatives that
we're working on and our goal is still to drive that number closer to 50% within the next couple of years. That will come from both current
centers that we have that we put in with some of our current joint venture partners as well as new joint ventures that we're starting
to get some inbound calls from about this opportunity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">I think that RadNet's health system initiatives
for joint ventures has really started to take root. And a number of the systems that we work with are so large and have other sites and
even states that we could potentially move into as long as we can do that with joint venture partners that we're getting a very good inbound
calls from people that want us to look at venture even beyond the core markets that we're currently in.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So we're as confident that not only that strategy
itself is a good strategy for us, but that the opportunity to grow our imaging centers into almost half of them being in joint ventures
is very realistic.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We'll take our next question from Mitra Ramgopal
with Sidoti.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mitra Ramgopal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, a couple of questions for me. First, I was
just curious as it relates to the tight labor market and the significantly higher costs you're incurring, if there's anything you can
do to help maybe mitigate some of the impact?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, there are and they are initiatives that we
started working on last year. Many of the equipment manufacturers have developed new tools, which shorten scan times and allow remote
operation of some of our equipment. Both of these, we believe, will have the ability for us to improve our capacity for helping manage
the demand that we have, while not necessarily requiring additional labor, particularly technologists, to perform them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That is a big part of our 2022 and rolling into
2023 initiatives. And we that along with artificial intelligence, which we think can create additional capacity both at the scanner level
as well as efficiency by our professional and nonprofessional staff, we think will help address some of the labor shortages. So I think
there is a bright light on the horizon about addressing the labor shortage, not with just the -- trying to find more and more technologies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">But how to create additional capacity within our
existing centers without necessarily needing to increase -- part of that, so thank you for bringing that up because it is a big initiative
that we're working directly with almost all of the OEMs for tools that they have or tools that we're trying to suggest to them in the
way of equipment design that will help facilitate throughput capacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mitra Ramgopal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay, no, that's great. And then just back on
the AI division. I know it's still very early days here, and you're anticipating a loss of $12 million to $17 million this year. Just
a big picture in terms of your expectation for when, you might expect this division as a stand-alone to start breaking even and eventually
contributing to profits?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay. This is a bold initiative, but it's something
that I think has to be done, whether it would be done by RadNet or somebody else. We believe we have right milieu to create these opportunities.
Based on some of our preliminary numbers, we think that within 24 months or thereabouts that the AI division will start contributing positively
to the company's profitability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If indeed that's the case. I think whatever the
burden from a cash burn standpoint, it takes over the next 2 years will be well worth it, not just for RadNet, but for the industry as
a whole. All of this could be facilitated to the extent that the President's plan to revive Cancer Moonshot is taken up very seriously
and a number of initiatives that we think they should be doing, such as expediting FDA approval for 510(k) clearance of some of our new
algorithms.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Helping to create screening networks and engaging
people like RadNet, who clearly understand the outpatient world into the discussion. We have entered the portal and hope to be part of
the summit, which I hope will take place somewhere next -- in the next 60 to 90 days so that our voice, not just as RadNet, but as a steward
for the potential opportunity to make cancer screening, using imaging a reality is heard, and we are engaging a number of resources inside
and outside the company to try to jump-start that.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So the 2-year perspective to make this division
more contributing to the company's profitability could be shortened if we are effective in having our voice heard both on local levels
with payors and on a national level with the federal government.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mitra Ramgopal</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Okay for additional color. And then finally, just
as it relates to Omicron I'm assuming now as we're sort of exiting the first quarter by 2Q going forward, you should be anticipating back
to normal levels in terms of patient volumes, but also internally with your workforce not being as impacted as you saw in 4Q. Is that
fair?</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Yes, it is. I think assuming that there's not
another surge over the horizon and -- and who knows what impact the current geopolitical issues may have. We're very optimistic that not
only do we see our volumes returning to normal, but also a lot of the delayed care that people experienced during the 2 years that we've
been in COVID, I believe, are starting to come together.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">So the opening up of the cities, the major metropolitan
cities that we predominantly have centers in, should have this kind of an impact. I may note that to the extent that people read the press
release from the White House about Cancer Moonshot there. The headline in their press release was that they estimated that 9.2 million
women did not receive their normal screening mammography during this 2-year period and the potential for a large increase in the number
of identified cancers was likely.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">That same logic applies to lung cancer, prostate
cancer and colorectal cancer, given that those are all elective procedures that people clearly did not undertake as normally as they would.
So the prospects for the opportunity to really reengage the public and to heighten that but hopefully, some efforts on the part of the
federal government and the payors could have substantial implications not only for RadNet, but all imaging providers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have no further questions in the queue. At
this time, I'd like to turn the conference back to Dr. Berger for any additional or closing remarks.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Howard Berger</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Again, I would like to take the opportunity to
thank all of our shareholders for their continued support and particular employees of RadNet for their dedication and hard work. Management
will continue its endeavor to be a market leader that provides great services with an appropriate return on investment for all shareholders.
Thank you for your time today, and I look forward to our next call. Take care and stay safe.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Operator</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and gentlemen, this concludes today's conference.
We appreciate your participation. You may now disconnect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 11; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>rdnt-20220301.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaSBqaPty552SYkxvmRzfQmqfyAq47Xc7SeSlUwWwZ4L -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:RDNT="http://radnet.com/20220301" elementFormDefault="qualified" targetNamespace="http://radnet.com/20220301">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://radnet.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20220301_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rdnt-20220301_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>rdnt-20220301_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>rdnt-20220301_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://radnet.com/role/Cover" xlink:href="rdnt-20220301.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://radnet.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" !G /T# 2(  A$! Q$!_\0
M'  !  (# 0$!              4' P8(! (!_\0 31   0,# 00%!@@(# <
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M 8K6MND-4JTV0@9;1<$[WBA0%61'2$,-H3P2E( ]E!]TI2@XLMWSVLGK^/\
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MHJ$M-)NS>ZE P$Y0<@#J'$UDF_/E#^MO])5?M^^>Z#];,_J4)8MJCKMTVB?
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$E*#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140256911100584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  01,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>radnet_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20220301.xsd" xlink:type="simple"/>
    <context id="From2022-03-01to2022-03-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-03-01to2022-03-01">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-03-01to2022-03-01">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2022-03-01to2022-03-01">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-03-01to2022-03-01">2022-03-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-03-01to2022-03-01">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-03-01to2022-03-01">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-03-01to2022-03-01">001-33307</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-03-01to2022-03-01">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-03-01to2022-03-01">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-03-01to2022-03-01">Los Angeles</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-03-01to2022-03-01">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-03-01to2022-03-01">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-03-01to2022-03-01">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-03-01to2022-03-01">478-7808</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-03-01to2022-03-01">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-03-01to2022-03-01">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-03-01to2022-03-01">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-03-01to2022-03-01">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-03-01to2022-03-01">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-03-01to2022-03-01">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-03-01to2022-03-01">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-03-01to2022-03-01">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ML0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1&+9
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M8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0
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M3R54&*!\4YFHO/93;#GICEYG>O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0
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ML;S63AI_YHOA/UY_ 5!+ 0(4 Q0    (  FG850'04UB@0   +$    0
M          "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ ":=A
M5,@0=FCN    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N
M>&UL4$L! A0#%     @ ":=A5)E<G",0!@  G"<  !,              ( !
MS $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  )IV%4+N=./28$
M   ?$   &               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N
M>&UL4$L! A0#%     @ ":=A5)^@&_"Q @  X@P   T              ( !
M:0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  )IV%4EXJ[',     3 @
M"P              @ %%#P  7W)E;',O+G)E;'-02P$"% ,4    "  )IV%4
MJL0B%C,!   B @  #P              @ $N$   >&PO=V]R:V)O;VLN>&UL
M4$L! A0#%     @ ":=A5"0>FZ*M    ^ $  !H              ( !CA$
M 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ ":=A5&60
M>9(9 0  SP,  !,              ( !<Q(  %M#;VYT96YT7U1Y<&5S72YX
8;6Q02P4&      D "0 ^ @  O1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>122</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="radnet_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://radnet.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="radnet_8k.htm">radnet_8k.htm</File>
    <File>radnet_ex9901.htm</File>
    <File>radnet_ex9902.htm</File>
    <File>rdnt-20220301.xsd</File>
    <File>rdnt-20220301_lab.xml</File>
    <File>rdnt-20220301_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "radnet_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "radnet_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20220301_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20220301_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20220301.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 122,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "RDNT",
   "nsuri": "http://radnet.com/20220301",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_8k.htm",
      "contextRef": "From2022-03-01to2022-03-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://radnet.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "radnet_8k.htm",
      "contextRef": "From2022-03-01to2022-03-01",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://radnet.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001683168-22-001373-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-22-001373-xbrl.zip
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M \$"8%UA13ZL\-=HL,[L12TJME3;VQ=1X],ER"^/\"Q;"FMVREL%9D\W%_M
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M?%/RI'FIW7^56GV[>5Q-5ZT\O7UXZ'OL^']02P,$%     @ ":=A5#1AT3L
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MICR U QT Q+<_/;0'GFZ-K90=X4- FE. 6XN9R83,.^0&46NT4C< MPBGY7
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M4E*D[A *GDY9R0E9P$]&)YZI$?'_+<$J\N)M)K#&P-/<]1"U90XGB[+BJ<A
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MCKJY;\N9\'[NHJZ ;#ID!5'9=:2"5T,%I$$'1B<+;$X"B0G-2XE,;K35@56
M06P2M03U&$'9ANH*;3KX1"2I(M/GWNX),B6"C ?.:X2HPRJR0XTB*00<KX$L
M C7>([UFKG, 3 Z-]&#2H75,OI[HO,G@T#1]*GJB(GD?J??54&]$Q1".P%"M
M"_V*0<0&4[4Y$=Z)OWU;+PQ&Q*7DD5Q>"[FL*?*$&U&U7)%<')6!G %.T)^O
M!R5K<\T:(ET:CB3T6DAH05ZB,",M.^J7%3HTK^;@'"=J9EG",<Q;W80M0*AO
MC$=E>*(>#RN91L(40)\:_,>UC\3T:H@)S%R@$:(E(U+=*LJH2;91I,#%#)%B
M0="5D%59T4&>'TR3-U@[Y@WN(&^P=O!Y@T=^FWM^2_K?$&A3Y359)+01)V&$
M8"?$=E7'HI9J&"Y"$3TGV"FV)!(A?-S-HW+W>N@C8D[ZCI")\4OR7=?X!X^,
M^([J8D%XJC^DA3P^4D'NJ6"HF^HC$0%&AHQ['J(0[BS,S W2-T4"Z/#( E[-
MX8>1D(%J_<1(CD;5^SS.C^6V/(##IN-'ER>!%@M $_.82'Z4YT@8KX8PXC'A
MJ8W>'<1?C> 91%.ZBX4APBS84\XZ1/ZUKTQP3 J">>$6'<^8H1B@M9!E&89T
MR56.,> ( $.8FTF@+R/@44-R=Y_CX&W-^P#'<"3$5T2(,*#.09^XMWHA$84W
MP54#6/D(J5&VUH0J3J+Q>0Z38NIWANL'^,-@/P730T 4W:)(-U$[%0%A/_A'
M-M*'Y("GY%",.?LC8&0;W1=^--P,$YM%;@0!G@3(3#PX)!IJ4Y9%%)Z'_"$D
MA@D608AB6A#O>^IG=P5)(<(O>PQ>OKJK@.TR>-L<H 0PX3!%*)9VR0%TR,W*
M?;'\@R#MTIC/G')ACZ:$TQ,V%!=9ITA%H=W'?!+T\SC^6SB&#9YQ VJD@=UT
MQ?<NW#!J%F&(1+!C>. 54B0Q8HV+> )Y(5P)<<Y21&4P+-?/K"']45,]%3N@
M3(&?BS*(HTWYNN@"Y)?#H;-)J$7^'''?$_$;-]0>(_44(KD/2V2F!O^GR, @
M'H6EO4/#I?)6GM5U))W70CJ6;45294#1FKDB8<9ZY.B$Z,Q$58A*QX"=F.H#
M22?\@?8XP)I)_A6*.8Z'$VA+P5?H1P=-DH^/#V-UCC,D4Q8?O+=-'^6230QW
M+N-3(NRL<-"9I<Z\L>T8_T$RID1]AT!PN+RF8+MMC7BY%C'#H PR#E"[X:C6
MAH'[88N7U@GXN<Y^20$6._G6G\ =,T1U+D>W#0N Q<^P;5107X[YJ/S6@_6G
M_D2#DK>5$H8?HN3A. )BC0:?J$.=D,^HE!XQQ)AE1W*WB<E,9_"W!F-QI#VB
MFZ6+"K.;'X!NP RA8P?%7V*BOR"5F%"%%L_/QG):M%3AO\M2HV%?2&$;SA?)
M<'C-:)&LSQ#G#6M!=P\&-OG"KEQP8@AAB#C6#J_"CV27P?5X+9!*5$![&QAJ
M[.M[]K7=OB$BN;*M,_HC0+PJ%KKA5FZ\:#X/7<*HDC=6P^MG0H=E01&2*A8P
MLX)?1WY154U#!TJ0F(B;R#%O?0#O&2:8 Z\9A[MM^;L]T;%4@BP D<1/[7K"
M=_NH7G,CBD)1ER,WQS(>HR-+HG0J]D;5=0W7FT,:AV'X),@Q0"6S[OB,<YRY
MPKAE<T&@Q@A;@C]A[:,9)4F!3-!=;RYO/<AAT+G@0+-G(&KN,",&H9)U+$.9
MN3/A*H!E."B#'%&PX-SYJ?BD1Y.Y1'$[TH[XO U[Z,=AT/^.K 369'"W0+C@
M>;BUI*(P]0X)Q!.3%R!L<#0]GD<:+IP7MG%:&? Z%41^0/ #?+L[&P %>C./
M@VSB+@85'*"9:#,?XB&1N"11[O?(@N$1C=EG^D)0\WI;X-+P(A/E:O &C&32
M;^@YRT"(@>#VA\L.?A^ITIM?"R:AN+;@)<B\R:V2L$(I'!9+,\)]FCJ(E+GJ
M'MUB@J9&@ PBJRY&9<*M.4%$OLA6"&(7BS""*KR(= V+B#FF*#[G"H'("_,R
MY_P+* K)+P,M<KC?;SP'):U]WN^]9]M\:QSU93OOG4>9K,CELVJU=J8TR^5M
MSF(==,L )G-K$URM\AQ?M1%0O/HQN6T'R6WU@T]NV^+-BA^:[RM:\_5/-&*Z
M;5]<=?H@2Z[.2ZQ]!4?XXW.O>]%MWW8[O=U-"P1K[_JR>]'N=R[8Y_9E^^J\
MPWK?.IW^#B=UTKUB_6_7/WJP3SW6^==YYZ8/DVK?=FCG;CJWXB^8=OO4G^<2
M.))G.A7G^5(JOI-&JTO9"C327FT)XR%&]Z#C1>?;OZ1WY_DU+NOJ]S?U-TL?
M369=;5+U+W2-.L^ &B*M-X?T#>>>L=H/P)Z&&$$+*$>>>D]M@9):W*3<(L34
M7IQJPKP2QELF3_*[T/(F%IIU#\*TI-WK$8-;U4LPLIDK.G6^]/%,.E0^L0M<
MS3G_<7O;N>JS-'N1P/_Y(,E$_(0JDG[ /,TF:](5XJ1>?YMX6I@WSB%?X1_H
M:;ZG#CON$I502=?+64Y\V6]+!I67Z)ERI2K5R_5E3R6^8Z4ZO=W9EQ6I+#>?
M/?O,F\SR5[8UZE#HBC1A]#5AP,++^J[(E9I4KBMYN;JRTI)JS5J^[F[\[1<S
M$8\*X&#=K'>F)E6:U;P<4TUJ5F(,(0?W:(DZ=8..9"."YQ/&&()J'-?5X^PV
MO7*64B%+N^?KC"/.I-J2%#EVD1/5N+2SV*?E5Q2I%6<<SUA^UMS$GQ*^&61A
M.7E&?4)_3J;.K&YU1:E*2CTW3$9IE*6JLN9T=J=QW]Q>WW1N^W])K///']V;
M[Z1]7UVPV^[7;_VSZR]G/WJ=HSJ>6Y%^XV VKH#QB/0LWX(.5FW"O:LV\G)>
ME59+JE2VJ8.]4+Q?!\U.><"6UG%FC\YFU!AUWP5[#<FCE<X3]1HE>[59D>KU
M3:P_3Z)]*OB-%#(;7NZUG'@S,[K  FQ*M4K,2-X5!VHV09EKY<' 2"7YK_O?
M.K='T;YCT?[IJVT/L;% YL:O7)&:<8?YKLZ@VE"D9J.5@\N2<#/\/#[5NC.H
MK=56&%JM+M7+E;P<4$V1*JTU9[,#EQ9!A.L!WKV/)I:YE2?)Z^J:64K"1GU-
M/7Q+-ZE+^;$3WJEC'B @\R.J*I*BK,E@,C1/JE)-65-5V>%U\M1?@NN1+4GE
M*L*K@UGBE#R?,5%7I68M-]P0@TG-/-ZQ)<;EA4[PB1&?\3[;4I6Z5*X<L).X
M+K6:L:NPIY9DG&"54FT:&)CI'!_BD;7/BYYC0WL&6EVJ,.V:HP3:0;G6E*J-
MF!<X<1W/)]J<;P/H)4W0:6LQOOFL;=B%I>SGYEQVVY^[E]U^M],C[SCZROM_
MY=%.S==L=IQ:-9]4%#G$/.Y5OF:S[022J?K(LT=437-F>E+4.W.;KEZ16I7<
M!#04$/OU=9,G=I-4@CTGMY92HE2D6B4W?BPP4\KRFK/9TMT*C#D?NS/2B\FU
M1Q[VE&:N:F9_9')9:I1CH9#=10HE):Z3Y.U>G<^;V]3.4[1XH7AA]D)CJ+KC
MW,@P1:HUMND^27_-$@[*G@_M9KTW]9I4K>4F&1)FTVCE7&PM\9HD'*5E(]:>
MT$YX@V.$0<6.*=2C:9_]"K(LR?'$J<-QJ[2 4'<>H%_&:)Z3< <*F ^_E[D0
M;53!NL]-UEVEU91D.6=<)Y5U>GE]]?6LW[G]?K1/<RC<OT15KEV%0G*FBC6J
MN0\++^36[>K@:HV&5&_D)DY<K5>D<BX2E.*OO(KJ6;LZ+Z!LJ=K*34)975:D
MEISSR[8LNY5R:!"@:X5RLH]:HUR7*O5T=<>O46FNP0UIQFY(7I3F90KR%A5C
M66K M:W(N?$CRYAX(E5J>5>.WWPZ1M5R)9*C2&.(":_]',,Q$<H[)G][C^_S
MN#GYFLWV5=_\[D6^9I/=)<+FZPB\<R:3TV;>D2,O<>2<VY,)@FSB-6-G[+=2
MN5R6$4"4W:OF##1BI5R6ROS_F3M6$?\Q1)C^P$ NUZI )DJ#G)0U6:I7RU*M
MTO!_;+@NAE4IFCKS$%V8>CVHWAR:#D/T&/K1XJ=ER>^Y8]SKYF/FIE->:"OW
M5?UM 9*+U3FJ,03R.Q-MO#-WNE45J=;*3>"A4FY(C;ANF@M9VM:TV41 X(9
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MH+POJULBDB69@6P7.). 8R,<O$*@()%@"B) _")J&F05J>Y[:V]QTV],T2)
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MLH$0J8_^NV0HK F$GY3#S7*#4]5<K)=:XU$LME8P4S03D=.9G]!F;>-R&**
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M$EOE/:C?WBB_.@(&GAQ#$69:X&UGGIYW],?LJ;=5)^!;5C0^YQ';:!I84HO
MN<0Q!',(J@C[2Y'&=FLK>!11NMZ)=@?I7*Y6C-U:RU101H]#M:VY8]\HC JV
M;E\DQE''GDE28PR(2"Z+XDL7^>@.RII'9,O5+3!9BN7>L4$$#NAA?WEFC0L0
M^2EX"B7"I4]N /&MW90Y+&-FA8KQ4*5T4^@?]3LW ^:"(3WE0]+Z%Y_2^A\A
MK7_Q*:W_&^2G/I;@$>QH^C2D_)"8*?]WH#+CI06\6-]]&*\503,#=WH@A_6=
MC%-BEPH&A01&CLZ\=$8#G.TM8\E6)=D/C0-+A2_N,:L4N"]$O<,DVR*-_*AM
MF=J<'8$PJ=IAU3<8--4(XFL\380[QW9<0,[5-&K#3+K#J=4N.9H#81!^G6R+
M>8H8M<NA8'D%]_[L7H2!F8P2*[/&:#?$W>M,<L8T8'%"R=G$,^B5Q;YS1B)9
M56OQ4CI+PH,BI'UY?9/S,*Z-R5=JSW&;"+VXS)LNEZZ274?4A>K@]XX6U,Z'
ML#X!R9!AJ_!K$3I1-Q:!,#_SQ'#UB,.8]9L6$8L'9DPY#H0*(IT[*J\++XW]
M??*+#2"5Z?XUV>7 KV"'0W8OI*10B$"*?\?3NHAR$="7@6*2+PZ3Q#1]Q8DQ
M'HD1*MX1Z1=2V92UA.W=T.>)Q@S\=)O>;&89X<QY,MFKF@S=/$56;&M^*:L0
M!2HK7]X5HY1K_E+'XN$L'8[87!V,V)X_&XA4N:YE',=]Z![C'LXB=9[)"G-_
M^]!J\Q"Q?K?,XO+I!\8H/K=UYAS.]S*4"PLHS]_P4D,9#C]7LI[<]<@JVOLY
MN%_4]B-HB^3,ZEA8G<.@KIX;DLT%]6 J!LZN,A:S<>C2=<!AT+S,7^%N7!_1
M)+\UMS(8+^IKKQ-$OAGR)3Q3)T#Z\2P!OUPEJ9,, M9-)]LM _ CT+'=M@:,
M=%9OI,_F?CSZYB]U%""5Q>C]:/-JGF9YZ-;KVOP>0)3S'H3IJ'ZVD#RY,\S/
M3[6, "_1"JIS^J2GW(]T<L.:_(S;>'=DV&LX%F;Y@SV2L88J.8'\3R2OV9C*
M#??L!)#'(U?^M."QOSS+%W4'[YF/Z&NH9%!SP<"QQ_.4 Q$%D3$@>4YO!S2Q
M3.!LD$['4IQ4/[MK0D=8JIJ3V-*=R7*CHW40S.4JQN2PB+';)8.$& C"349H
M:Q5%QR;VL'D!]:7_1HBPK6J@&2SIMMQC&(R!3CQ;>,6/Z@P(K;0.&X;$] :^
M#^2X^:6@@E620PG(9#$GR\G!K;%1)[1/]/_Z'@H ]IT:9\Z+&MB.#.-MO!<T
MD-/YR3Y!%SOTO53IB%DB%"H1Z^=59HKDK2F(Q?.VT5%AWUB.\T+]_9"O![(;
MO5<=QDM];??)NMW30?VI+%-7EX5A.>N6W48)5DPP^87/'\"-C@  Z4C$GMP\
MN9-Q<:BJI4_XCOAZDJS+>C.!QP==58O56V@16%9'UBY7LMYH(HR]%8Q%JJV%
M#L ]G1/&HU;@=""'\*:<:,V?J5TKH6U:-[+9B/]MBGVS<?<AJT.;VIE46TDQ
MV&K+NF=K]@LKMX3?O=P@39(Z3T6SF+X6YGY3YK&U)'.5VST9CZ0-:RX/2/]S
M&)0RT,A53/83$6<( J@@/]#+1',O P:7&&#D9.VR1I!ZB&#RW!:(8X28#=FQ
MG&C5.8Q-MK2I:Q;B0(*I755&%&"1@0Z-\^8MUW[?V1!I"C A49FE,%!6NTHW
M\L;%L8C;3?SP<\WVK7E.0N6+T7EM'&!Q([C8GW?VOUKV%3X7['X>_E=A.J1/
MFK&9*C7XW+\=O8I+L,7S*M\RL^8HO&>^C+KX7? "4H8+O:"1BEY$"]//8V<(
MPQNE%E\ZUS.9)@BFSJ5HAGB4:]/@QF9W 7Z'0U(Z24+K4S6<)340+O9#/\Y1
MU.Q/4G!_[\T^I.P1#N0==V9U5/GOPS\9!T=85K#_V2U0'TKD>TA/^9"$X>6G
MA.%'2!A>?DH8_@;Y"6:<BMH@U(,JD3R($[SCD<2H$/$CR4H;XD4R?[%%(9T+
M9G(OA_Q0P^$<-6-Q/HGD>9BA)P H$A"3J#52"=YE=\TL"HHC475,02^;3AR-
M8Z@D[9-=9I>2U?!=+7&$GX<QDR*P(0M@TV!AQG,P,9P<4=@0S>?W]1#>JQ8!
MRYY>E&S)\2A:9#:XJ+Z$:=D<\%9!G,/PL;JF+-'>X:<RT4:#!> @:%P/4YAT
MMOVD.UB=Y$\)8X&5('X;+8070":X6:]5,>/H$%QB PT&E-6V./1S5@%[-@I&
M<6#88E<R;UG95%]DFER'PL6)VA4AR>'24[W6GVB/TE#'BUQV7JX#V%XO0;;-
MUM)1,!X9-@S@,[M$RXF4B4>&4==XD@Q+SQKHG!"_'_9C(#8"&X%HK4-4&J0O
M;IL[@-0NLU0.WVX7Q,3D;Q7],E20 IMVZ L3N+Y='HQ(N)3=B*08R"DL3^D
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MFS4!'9I_QZ3/>12I&L<I2O$"<PC9W7$-P.4I;GQU*H9'789ZX;LR6]J(98B
M8HY1W6^AZP(^5T!BZ^7SN)7C$$-.X&Q=CL\DBO,,=F T?C\N"$$9=P@=9O C
M:A255=A%85ECZ<I,*F XO[3;W8F(9JY2'@8QOQ&ZFI]PX70\2\;M?\=Z&X\4
MN+IKB[U''T55WQ*G0M7]RI^.!\4C^M*.#T]'.EN!@PH(FY5+!'\03G"M%JZO
MIF %32=L7(@(OPHEERN;HDH]0D0;R/$-Z2D?DOR;G7[*_GV$[-_L]%/Z[S?(
M44,-I$A[?A1DQ*#.*):B,\4GBL)TD/-S'3GHX^">)3;=,&>F=E6#I409[3LQ
M?0/B@@.*(9=S_F=%.*'EW+/=P>@EWI+N!& 0VF'?#8VL7H]U8BK.YM-6'S69
M@,K"B.HRX8QU&D=?8&C2DY>2-9%*)KPJ9Q!Y))VLQ]Q+7P!Y3JX\=&6RZE/@
MY-_UE3C'R/'JX.QZ,NW,CJ2#A^FJ19/<7^9=6Y_((*X@Z288QB6'$6M%?91&
M-076Y6K;-3DJ)6;=+[E,N,9L88!\P-& Q^%[!3%38"LC0EQ!'Z:<YHRVK/BM
M8LA)VUIEF[8JW' !9H&(OOWX+DD/YF9O4YX6)S=WL,!^*$J:I&WE^-*Y[Z%!
M=3QB"&NB>@'\B$<FFJ@F. *M77-D:2!6H1KU&-?%XS]V'AN%@UHR04;ZH;>V
MJ>3(4:.@PQM];3:YE:A3U^(';MGU%943)^DT+4Q>@A\Y42AM@7Y!/IB1J91[
M&/30T_70YMS6B.D] HOHFR0CR'/-SO7C(<P6@@P$($4>3"9^:U;U,-+O39RX
M00')5H(R^.QJZD/DY&@0@13D *4L9BN[M%(PCWNJ+ _^?S1C)9 H[4SPK[(R
M]<4E70ARH[70/MOE7&YV6QE!)QK_[*:.W)M:\6L&0KR<Y.:^8V1)EX@XY8J)
M"Q1S#R,>!AIIA."!D=T1^H2,D..ZC3Q')ZRXGM% DI@@77#&'3T':3A&PJBP
M.'E@#-3:WP%>F(Y'RGMA"+J+<O1B&UI)#\)9&^ED3W;M(L<;RSP5HC @SNG:
M%YQEW6%^)BP;#K.Y:7:'>$ZDX@]<WD!VXC5'B/\Q7 ;@K#(W4]S7:?=CG]QM
M&$#J!3)[(!3XKZJ1=@&\HO1X#Z&639F?/F@13&YT2CSJ>TB?/4DEF AQBBBW
M E^M2/[!+W-0B.BA%,M()$RQC\WF4GI]9$0EZM[^^0<X0&OM>FUD*K.DI/RQ
MZ'CA'M_+<*-;5T[ #>,;DDB;,D_=U&#1+8BQ944+U)V6;]&#B$OL%EB6UK+O
MH.FO<'EJ4^5B;:ZII :-:\X42UHG(;LG8<P=4".MN>,B!O9A7$$D"</4ZKA+
M#] CT-:UK>ZRI0U@/9PDV%498N-B^$%$9<4=$3=+(B9&9+JB5R?9^;93RB%3
M43,VSU*C<U%NI,%&/2XWNEXZT^B.I/PE9JPU-R35,.%\-13PMF&U;WQK4C<K
M?(W>)Q#EQ&7,BF7>IE;'VSVI(_%&E$*B$T1FETQC>QE.43EW&]F1GU&%P*;G
M/6=-,/-K^2GL^^_WE \*^\Z^2%[S%+OZ\^1;E,]^B@)_A"CP[%\:!?[(,=G/
MGK]^^?,?\9>OWW[W[1__/U!+ P04    "  )IV%4>AK$3CH#  #O"P  $0
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M=^@:;\DI^I%0PG'.^'?H&TYW<@N[3%+"T9QMGU*2$Y%0[O@4_?5H.ENC\7A
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MKPOH@H"EQYQQM[>4MV#QV!M=T#S)7^7S>->[[9IP2P%-B2L^('.*"ST]"!X
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MKJ!E^PHA*I3>&/B,Z2/?/>71ZRUG$2'R::VL;KGZKM$-C';+S9N*U"9J4&A
MK+W%+T#A(0O4R.-#H_?R?<%//HPN5YACT>/R 8N#>+/+,]FC"G/P%?/.(,>W
M(@840+LAT1$1$'X#;$(W)XI(5(1^0&4P:D1[/&_+#JL3DOCSZQVY)US.:5B1
M??Y9[.RQX\QC0*SKL[K!Q=%/\GH#@P#QK6ZA4\ ,-3- :_F<694%^E5F@HI<
M;.]I;VZZ$I_$9K5)_%KCC(@M_P502P,$%     @ ":=A5*LD\ =1!P  O5@
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M&??+O6O6'OD?4$L! A0#%     @ ":=A5!<PERIR$P  %W\   T
M     ( !     ')A9&YE=%\X:RYH=&U02P$"% ,4    "  )IV%4-&'1.P!2
M  "_= , $0              @ &=$P  <F%D;F5T7V5X.3DP,2YH=&U02P$"
M% ,4    "  )IV%4%J[!12%"   N10$ $0              @ ',90  <F%D
M;F5T7V5X.3DP,BYH=&U02P$"% ,4    "  )IV%4>AK$3CH#  #O"P  $0
M            @ $<J   <F1N="TR,#(R,#,P,2YX<V102P$"% ,4    "  )
MIV%4+^*J8/\*  !LAP  %0              @ &%JP  <F1N="TR,#(R,#,P
M,5]L86(N>&UL4$L! A0#%     @ ":=A5*LD\ =1!P  O5@  !4
M     ( !M[8  ')D;G0M,C R,C S,#%?<')E+GAM;%!+!08     !@ & 'X!
(   [O@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
